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Background and Introduction: Heart failure (HF) is a serious disease, which shows poor 
prognoses and high morbidity in both genders. This results in enormous challenges for 
caregivers, researchers, and policy makers in addition to suffering of affected person and his or 
her family. There is some controversy regarding the association between life style factors and 
the incidence of HF in men and women. The relationship between physical activity and smoking 
and risk of HF has mostly been reported irrespective of gender; however, similar doses of 
physical activity and smoking cessation may contribute differently to protection against HF in 
men and women. In the present thesis, a systematic review and a meta-analysis were carried 
out to investigate the influence of gender on association between smoking and physical activity 
with the incidence of HF. 
Methods: The meta-analysis and systematic review are based on literature identified by search 
in the MEDLINE, EMBASE and CINHAL databases up to February the 1st, 2019. Risk ratios 
(RR) and hazard ratios (HR) estimate from observational studies were pooled in a random-
effect meta-analysis. 
Findings: 2413 articles’ abstracts were reviewed and identified 9 population cohort studies 
(more than 3 million participants, 52.6% women), that adjusted for common cardiovascular risk 
factors.  
For analyses of the effect of smoking on HF, a total of 8 population cohort studies involving 
2,986,217 participants (48.55% women) with a mean range of follow-up time of 5.5 to 19 years, 
with 68,983 cases of HF (2.31% of all participants developed HF, and 48.0% of HF cases were 
women) were included. The risk of HF among smokers was higher than in non-smokers, with 
higher risks in women than in men. In women, pooled HR was 1.83; 95% CI, (1.62, 2.05), 
 
 
𝐼2=0.0% (p= 0.72), and for men pooled HR was 1.58; 95% CI (1.41, 1.75), 𝐼2= 38.6% (p= 
0.180). 
For analyses of the effect of physical activity, a total of 6 cohort studies involving 1,105,467 
participants (47.0% women) with the range of mean follow-up time of 5.8 to 19 years, with 
60,158 cases of HF (5.44% of all participants developed HF) were included. According to 
estimated effect sizes in the included studies, engaging in high levels of physical activity was 
associated with a significant reduction of HF incidence in both men and women. The effect of 
high levels of physical activity on the risk reduction of incident HF was stronger in women than 
in men. In women, pooled HR was 0.69; 95% CI, (0.61, 0.76), 𝐼2=0.0% (p= 0.676), and for 
men pooled HR was 0.73; 95% CI (0.66, 0.81), 𝐼2= 70.9% (p= 0.0.32). 
Interpretation: Smoking and physical inactivity increased the risk of HF. Risk increase was for 
both stronger in women than in men. It is not clear whether the different risk of HF among men 
and women is biological or related to the patterns of behaviors. However, policies addressing 
smoking and physical inactivity should consider gender specific adaptations particularly in 
those countries where women are less physically active than men, while at the same time 
smoking prevalence is increasing among young women.  
Key messages 
 This study presents a review of population-based cohort studies, which include contemporary 
health records from more than 3 million adults with more than 60,000 HF cases. 
 A heterogeneous association between current smoking or being physically active and incidence 
of HF in men and women was observed.  
 The effect of two important health-related behaviors on HF stratified by gender, which have 
seldom been studied in large scale cohort or reviews, was investigated. 
 The findings suggest differences in underlying HF mechanisms between men and women 
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1 Introduction 
1.1 Background 
According to World Health Organization (WHO), cardiovascular disease (CVD) is one of the 
four most prominent chronic diseases (1). Modifiable biological risk factors for CVD include 
smoking cigarettes, sedentary life style, being overweight or obese, having elevated blood 
pressure, and elevated cholesterol (2, 3). Among the non-modifiable risk factors, sex may 
impact the risk of CVD biologically but also behaviorally; for instance, physical inactivity and 
smoking cigarettes are not equally distributed between men and women (4). 
1.1.1 The global burden of cardiovascular disease 
 CVD refers to a group of diseases of heart and/or blood vessels (5). CVD includes coronary 
artery disease (CAD) resulting in acute coronary syndrome (ACS) and ischemic heart disease 
(IHD), peripheral artery disease, cerebrovascular disease (stroke), hypertension, myopathies, 
valvular disease and several other conditions (6). Despite all progress in research and significant 
advances in therapies and preventions, CVD is the leading cause of death among men and 
women worldwide (7, 8). The global burden of disease (GBD) study estimated that CVD caused 
29.6% of all deaths (more than 15.6 million deaths) in 2010, which is more than double the 
number of deaths caused by cancers. CVD deaths are estimated to grow to more than 17.3 
million deaths per year and are expected to grow to more than 23.6 million deaths by 2030 (9-
11), (Figure 1). Over the last decade, the age-standardized prevalence rate of CVD and 
disability-adjusted life years (DALYs) due to CVD have been falling in most countries, 
particularly in Northern, Southern and Western European countries. However, CVD is still 
responsible for the loss of more than 64 million DALYs in Europe (23% of all DALYs lost) 
(12).  
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Figure 1 Percentage of CVD deaths in each region, From GBD study, 2010 (13) 
 
1.1.2 Burden of CVD in Norway  
According to statistics reported by Norwegian Cause of Death Registry and Norwegian 
Cardiovascular Disease Registry, mortality due to CVD in Norway peaked in 1970 and has 
fallen since. From 2000 until today, there has been a strong decline in mortality from CVD in 
all parts of Norway. During 2000-2013, the mortality rate was almost halved (14). CVD risk 
factors have improved, demonstrating a decrease in blood pressure (BP), cholesterol levels, and 
smoking (14), however, CVD still causes most deaths in Norway. The superior longevity in 
women tends to increase the overall prevalence rates and number of deaths on a sex specific 
basis (Figure 2).  
 
Figure 2 Number of deaths from CVD in Norway, 2000 to 2013 (14), The greater longevity in women tends to 
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1.1.3 The impact of heart failure  
Cardiovascular diseases culminate in heart failure (HF) (15-17). HF is a serious complication 
of a wide variety of heart diseases. Coronary artery disease (CAD), either alone or in 
combination with hypertension (HTN), seems to be the most common cause of HF particularly 
in industrialized countries (18) (Figure 3). HF contributes to  poor prognoses and high morbidity 
in men and women of the western world as well as worldwide (8, 19, 20). In the USA and 
Europe, HF is responsible for a large proportion of mortality, and diverse morbidity which leads 
to diminished quality of life (QOL) in affected patients and their relatives (21). The gradual 
adoption of a western lifestyle in developing countries may lead to a pandemic of HF in the 
future. It is estimated that HF afflicts 26 million people worldwide, and the prevalence is 
increasing as the population ages (22). In western Europe and the United States alone, more 
than 6 million people are diagnosed with HF annually. In these regions, over 1 million 
hospitalizations have occurred due to HF (23). Consequently, HF poses high health-care-related 
costs resulting in a great burden on both patient and society (24). HF affects 5.7 million people 
in US, and among Medicare recipients, represents the most common reason for hospitalization, 
with annual costs of more than 30$ billion in treatment expenditure and lost productivity (25, 
26).  
 
Figure 3 Percentage breakdown of deaths attributable to CVD, USA, 2013  (26) 
According to controversy in HF diagnosis, HF is not a true underlying cause of death and HF may accounts for 36% or more of 
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1.1.4 Heart failure in Norway 
According to the Norwegian Cardiovascular Disease Registry, in 2012, HF as underlying cause 
was responsible for 11.35% of all CVD cases (14) (Figure 4). The prevalence of the HF is 
expected to increase as the population ages. Sex-specific differences exist in development of 
HF and addressing these differences can have an impact on HF prevention (27).  
 
Figure 4 Cause of CVD death in Norway, 2012 (14) 
 
 
1.2 Terminology, assessment and paradigms 
1.2.1 Heart failure definition 
HF is defined as reduced ability of the heart to pump and/or fill with blood to supply blood to 
the tissues commensurate to the metabolic needs or these needs are only met after compensatory 
adaptation (22, 28-30). Clinically, HF might be labelled a syndrome without uniform diagnostic 
criteria (28, 29). Repeated attempts to develop an agreement for exact description of the clinical 
syndrome of HF have been done, however, no single conceptual statement for HF diagnosis 
has withstood the test of time (31). In spite of this, at the individual level, the New York Heart 
Association criteria for HF classification based on symptoms and clinical examination is well 



















MI and Angina treated with
angioplasty
 
Page 5 of 97 
1.2.2 Heart failure pathophysiology 
HF is a progressive disorder often linked to an index event which either damages the heart 
muscle or, alternatively, disrupts the ability of the myocardium to generate force, thereby 
preventing the normal contracting of heart. The index events are varied; they may be myocardial 
infarction (MI), or hereditary as in the case of genetic cardiomyopathies, or a result of volume 
overload and increase in hemodynamic pressure. Regardless of the nature of the index events, 
the feature of HF is common: the pumping capacity of the heart declines (13). 
1.2.3 Classification of heart failure 
HF is now often characterized based on echocardiographic examination and measurement of 
ejection fraction (EF): HF with reduced ejection fraction (HFrEF; EF ≤40%), HF with 
preserved ejection fraction (HFpEF; EF ≥50%), and HF with mid-range ejection fraction or 
borderline (HFmrEF; 41%-49%) (22, 32, 33).  
HFrEF is associated with poor contractility and systolic cardiac dysfunction, whereas HFpEF 
is associated with impaired myocardial relaxation and diastolic dysfunction (34). About half of 
the HF patients have a HFpEF (20). Also, about 50% of hospitalizations due to HF is related to 
HFpEF, which is more common at advance age and in women (35). The HFpEF and HFmrEF 
remain without effective proven therapies and represent an important challenge in the future, 
particularly in developing countries (22, 36).  
1.2.4 Presentations of heart failure 
In most cases, after the initial decline in pumping capacity of the heart, patients will remain 
asymptomatic or minimally symptomatic or symptoms develop only after the dysfunction has 
been present for some time. The explanation for this is that a number of compensatory 
mechanisms become activated to modulate left ventricle (LV) function within a 
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physiologic/homeostatic range, so the patient’s functional capacity is preserved or is depressed 
only minimally (13). End-organ changes with LV remodeling happen as the result of sustained 
activation of neurohormonal and cytokine systems, which cause symptomatic HF. However, 
LV remodeling is sufficient for progression of HF independent of the neurohormonal status of 
the patient. Experimental and clinical evidence suggest overexpression of biologically active 
molecules causing HF progression by exerting deleterious effect on heart and circulation (13, 
31).   
1.2.5 Etiology of heart failure 
According to clinical trials and registers, the etiology of HF can be ischemic or non-ischemic 
heart disease, hypertensive heart disease, idiopathic dilated cardiomyopathy (IDCM), and 
valvular heart disease (VHD) with or without comorbidities of diabetes (DM), hypertension 
(HTN), atrial fibrillation (AF), angina, and respiratory disease. According to the Framingham 
heart study in 1965, hypertension was the most common cause of HF, as a primary cause in 
30% of men and 20% of women and as a cofactor in another 33% of men and 25% of women. 
However, as CAD became more prevalent, CAD was increasingly identified as the cause of 
new cases of HF, increasing from 22% in the 1950s to around 70% in the 1970s (18).  
1.2.6 Heart failure risk factors 
Due to the first NHANES epidemiologic follow up study, risk factors for HF include male sex, 
physical inactivity, cigarette smoking, overweight and obesity status, hypertension, diabetes 
mellitus, coronary heart disease (CHD) and valvular heart disease (37-39). The distribution of 
the aforementioned risk factors, and the prevalence and manifestations of HF, however, differ 
among men and women. 
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1.3 Smoking and physical inactivity as modifiable risk factors 
for heart failure 
1.3.1 Cigarette smoking, CVD and heart failure  
According to WHO, 5.4 million deaths annually are attributable to smoking cigarettes 
worldwide (40, 41). If the current trend in smoking continues, by 2025 ten million deaths per 
year are anticipated due to smoking (42-44). Amongst all deaths caused by tobacco smoking, 
35-40% of them are related to CVD (45, 46). Tobacco increases the risk of CVDs not only for 
active smokers but also, for passive smokers the risk of CVD increases to 25 to 30% (47). 
Smoking is a mixture of several toxic chemicals (48, 49). In the pathogenesis of HF, carbon 
monoxide, nicotine and oxidant chemicals are commonly implicated (50). Tobacco has 
numerous effects on the human body, which may contribute to foster development of HF. These 
effects include endothelial dysfunction, insulin resistance, alteration in lipid profile and hyper 
coagulated state. The synergy of all these pathobiological mechanisms may cause 
atherothrombosis and HF (51).  
1.3.2 Physical Activity, CVD and heart failure 
According to animal and human studies, physical activities and exercise cause structural and 
functional cardiovascular responses which reduce the risk for chronic disease (34). Physical 
activity is defined as any bodily movement produced by contraction of skeletal muscles which 
results in energy consumption above the basal level (52). Physical activity may be categorized 
into occupational (associated with the performance of a job), commuting (daily journeys) and 
leisure-time physical activity (with sports, recreational, and exercise/training, performed during 
free time based on personal interests and needs) (53). Physical fitness is defined as the ability 
to carry out vigorous tasks without fatigue with ample energy to enjoy leisure-time pursuits and 
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to meet unforeseen emergencies (52). In healthy general populations, cardiorespiratory fitness 
and aerobic physical activity significantly reduces the risk of CVD morbidity and mortality (54-
58). Physical activity modulates biological pathways relevant to atherosclerosis, myocardial 
ischemia and myocardial infarction (MI), blood pressure regulation, lipid and lipoprotein 
metabolism, insulin sensitivity, glycemic control, adiposity distribution, skeletal muscle mass 
and function, oxidative stress, immunologic reactivity, demand/supply of cardiac oxygen, and 
myocardial electrical stability. All these factors lead to beneficial structural adaptions for HF 
prevention and improve the health status of HF patients (34).  
1.4 The role of gender and sex in heart disease and heart 
failure risk factors 
The term “sex” refers to physical and physiological features. This reflects the biology at the 
cellular level as well as the integrated physiology of the individual including chromosomes, the 
hormone levels and functions, and reproductive systems (59), whereas the term “gender” 
additionally refers to the socially constructed roles of people in the term of typical habits, 
behaviors and attitudes typically associated with males and females (60). In the present thesis, 
we refer to sex and gender differences between men and women as “gender” differences to 
incorporate sex-related (biological) and gender-related (sociocultural) dimensions. The factors 
associated with development of HF differ to some extent by both sex and gender aspects (61, 
62). According to the sex definition, differences in HF between men and women are mainly 
related to pathophysiological mechanisms, whereas the gender definition suggest that 
differences in HF between men and women are mainly explained by differences life style 
factors.   
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1.4.1 Sex differences in cardiovascular pathophysiology  
Generally, females differ from men in several aspects, including having smaller ventricles and 
stiffer hearts, with hypertrophy, apoptosis, fibroblast and proliferation being typically less 
pronounced in aged female hearts (63). Moreover, compared to male hearts, female human 
hearts adapt differently to pressure overload (8). Physiological myocardial hypertrophy (MH) 
may be a result of exercise and pregnancy (64), and transition from physiological MH to 
pathological MH is less common in females than in males (65). Interstitial fibrosis appears 
more often in male hearts than in females’ (66). In terms of myocardial structure, a study has 
shown that change in myocyte numbers and myocyte sizes differ considerably between men 
and women (63). There are wide variations in male and female sex hormones. There are sex 
hormone receptors in extra-gonadal tissue including the heart related to the hormonal effects 
on the myocardium and cardiac vessels and their coordinated regulation of functions (8, 15, 67, 
68). HF in the female heart is often diastolic because of diabetes and hypertension, whereas HF 
in male heart is often systolic associated with CAD (8). 
1.4.2 Gender differences in heart failure  
HF decreases quality of life (QOL) for patients and their relatives. QOL in HF patients 
decreases because changes in skeletal muscles, lungs and circulation contribute to fatigue, 
dyspnea and limited exercise capacity (69). There is a study that has shown physical health 
status and social functions among women with HF are worse than in men with HF (69). Women 
more frequently have HTN, DM, obesity, and other attributable risk factors for HF, and 
impaired myocardial metabolism is more severe in women than in men (8).  
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1.4.3 Epidemiology of heart failure in men and women 
HF is becoming a large and growing public health burden, especially among women at 
advanced ages (70). Epidemiological studies show a higher incidence of HF in women than in 
men in adults older than 55 years (27). HF seems to develop at more advanced ages in women 
than in men (15) (Figure 5). Approximately 10% of 70-year-olds are affected by HF, and the 
prevalence of HF is continuously increasing with advancing age. Women with HF are older 
than their male counterparts due to their longer lifespan (8, 15). In women, HF accounts for 
35% of all cardiovascular mortality and the higher incidence is related to post-menopausal ages 
(71). Among women, the underlying cause of HF differs in premenopausal and post-
menopausal women. In men, HF mainly presents with CAD and MI, while in premenopausal 
women LV dysfunction is the frequent underlying cause of HF, and in post-menopausal women, 
HTN is the predominant underlying cause of HF (17, 71).  
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1.5 Role of gender in smoking and physical activity 
1.5.1 Gender-specific patterns of smoking  
The pattern of smoking behavior among men and women varies by time and society. For 
decades, in some societies, women were less likely to smoke cigarettes than men, due to 
widespread social disapproval of women’s smoking. However, during the mid-twentieth 
century, in some western countries including USA, smoking adoption by women increased due 
to a general liberalization of norms for women’s behaviors, increasing equality between the 
genders, and growing social acceptance of women’s smoking (73). Socially and financially, 
women have become more equal to men, which contributes to changes in women’s behaviors 
with a shift toward men’s behaviors, and the behavioral pattern of smoking is no exception. In 
contemporary times in some societies, the general characteristics of traditional male roles and 
men’s greater social power generally contribute to widespread social pressures against 
women’s behavior and greater restrictions on women’s smoking. Another issue is related to 
traditional female role expectations that cause gender differences in personal experiences and 
influence smoking adoption by women. Some aspects of female roles have contributed to 
gender differences in costs and benefits of smoking such as physical attractiveness that is more 
emphasized for females. The beauty ideal of being slender is an incentive of smoking for 
women (73). Currently, one fifth of world smokers are women which contributes to annually 
1.5 million deaths of smoker women out of 5 million occurred directly due to tobacco (41, 74). 
Some countries have reported an increase in smoking among young women compared with 
young men. Smoking might affect men and women unequally, which is shown to be true by 
some studies (27, 75-78), and there is debate about whether potentially sex difference influences 
the effect of risk factor for different CVD phenotypes e.g. HF. 
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1.5.2 Gender-specific patterns of physical activity 
The health benefits of physical activity is well documented (79, 80), and a sedentary lifestyle 
has been observed in populations of both developing and developed countries (81, 82). There 
is inconsistency in studies as to whether men are more active in leisure-time than women (82-
86), but recent data suggest there is no gender differences in terms of the sum of all-domain of 
physical activity (87). However, the involved variables that are associated with physical activity 
and the pattern of physical activity in women and men fluctuate considerably in high, low or 
middle-income countries among traditional and modern style of living. Also, there is a strong 
association between socioeconomic level and leisure-time physical activity (88, 89). The bias 
of gender and sex is exemplified by the fact that men more likely tend to practice sports while 
women mostly perform daily walking (90). Lower levels of education are associated with low 
levels of physical activity, which may have negative health effects (91, 92), potentially 
impacting women more than men. Some studies suggest that gender differences in physical 
activity are age-dependent, with middle-aged men and older women being more sedentary (93).  
Considering such epidemiological information might contribute to improving the long-term of 
cardiovascular health for men and women.  
1.6 Rationale for the study 
Although improved primary prevention and recent advances in treatment have led to increased 
survival of CAD, HF is still a major consequence of CAD, MI and hypertension (35, 94-102). 
By considering gender differences in the pathophysiology of HF and health-related behaviors, 
this review will contribute to increased understanding of HF as a major public health burden 
worldwide. CVD and risk factors are expressed differently according to gender, a perspective 
that is often neglected by traditional medicine. While the pathophysiology of development of 
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HF in men and women is different, many of the protective approaches for HF prevention are 
still similar for men and women. Recent studies suggest there is a lower risk of developing HF 
in adults who are physically active and non-smokers (103-105). Strong evidence reported the 
protective effect of regular physical activity against CHD (HF risk factor) (37, 106-108). 
Benefits of physical activity for risk of HF has been reported irrespective to genders, while the 
same dose of physical activity may have different protective effects against HF in men and 
women. The link between smoking and CVD is proven and well-documented. Regarding HF, 
smoking cigarettes is a leading cause of preventable HF (39). Generally, the focus of previous 
smoking research has been on other CVDs’ phenotypes such as MI, CAD, or fatal HF among 
patients rather than general population. Research addressing non-fatal HF stratified by genders 
have been less commonly studied (109).   
1.7 Aim of the study 
The main objective and purpose of this thesis was to examine evidence for potential gender 
differences in the association of physical activity and non-smoking with risk of HF in a general 
population by conducting a meta-analysis and a systematic review.  
Four main goals were addressed: (a) To examine the association of smoking and physical 
inactivity with risk of HF. (b) To examine whether the included study results are homogeneous 
and consistent. (c) To obtain a global effect size of the relationship between smoking, physical 
activity, and HF. (d) To examine whether the association between smoking, physical inactivity 
and HF differ between men and women.  
It was hypothesized that gender plays an important role for the effect of smoking and physical 
activity on the risk of HF, and that similar doses of physical activity and a similar history of 
smoking have different effects on the incidence of HF in men and women.  
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2 Method of the study 
2.1 Design 
Using a meta-analysis and a systematic review, available scientific evidence of the association 
of smoking and physical activity with HF in men and women was reviewed and discussed. 
2.2 Criteria for considering studies for this review 
2.2.1 Types of studies 
Observational cohort population studies that directly compared men and women are considered 
eligible to be included in the review. 
2.2.2 Types of participants 
Furthermore, studies had to include general populations in community settings (free of CVDs), 
that were followed over time, irrespective of age and ethnicity. 
2.2.3 Types of exposures 
Exposure must include cigarette smoking and physical activity. We sorted exposures to 
smoking vs non-smoking, and high physical activity vs low physical activity.    
2.2.4 Types of outcome measures 
The outcome of interest is incidence of HF. The result is considered as binary outcome:   
Difference in incidence of HF was measured between smoker vs non-smoker men and women. 
Difference in incidence of HF was measured between high physical active vs low physical 
active men and women.  
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2.3 Search method for identification of studies 
The MEDLINE, EMBASE and CINHAL databases were searched for eligible studies. For 
assessing the effect of physical activity, studies published from January 1st, 1995 (in 1995, the 
physical activity categorization changed due to statements by U.S. Centers for disease control) 
(110) to February the 1st, 2019, are considered. For assessing the effect of smoking, studies 
from inception 1995 to February the 1st, 2019, were considered. The search was conducted by 
using the following combination of medical subject headings (MeSH) terms and free words of 
“smoking”, “smoking tobacco”, “smoking cigarettes”, “physical activity”, “lifestyle factors”, 
“exercise”, “sedentary lifestyle”, “physical inactivity”, pairing with “heart failure”, “gender 
differences”, “sex differences”. The controlled vocabulary of MeSH from PubMed/MEDLINE, 
and (Emtree) from EMBASE, including subheadings, publication types and supplementary 
concepts, were used. The objective was kept in focus by avoiding too many different search 
concepts by using a wide variety of search terms in combination (text words, mesh term, 
Emtree), and by using “or” between them. This made our search strategies sensitive in the 
different search engines. In the main database search, the combination of four sets of entry 
terms were applied (Figure 6). The search was performed three times. The search details are 
provided in the supplementary search list in Appendix 1. The reference lists of the identified 
studies and articles were also manually screened to identify any additional relevant studies. The 
language was limited to English.  
 
Figure 6 search term boxes 
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2.4 Assessment of risk of bias in included studies 
The assessment of the methodological quality of included studies was done according to the 
Cochrane Collaboration tool for assessing risk of bias (111). Six domains of bias were assessed: 
(i) Selection bias. (ii) Performance bias. (iii) Detection bias. (iv) Attrition bias: incomplete 
outcome data. (v) Reporting bias: Selective outcome reporting. (vi). Other sources of bias and 
potential threats to validity. 
All selected studies were assessed and categorized into high, low or unclear risk of bias for all 
aforementioned domains. The details are summarized in Appendix 2 and Appendix 3. 
2.5 Data collection 
2.5.1 Data extraction and management 
Results from studies that met the inclusion criteria were extracted. The risk ratios (RR) 
estimates and the hazard ratios (HR) estimates from cox proportional analysis with 95% 
confidence intervals (CIs) with available p-value for related risk factors of HF among men and 
women were extracted from included studies and analyzed. The following information was 
extracted and recorded for each study using a standardized form: name of the first author, year 
of publication, country of the study, study design, study name, mean follow-up duration, 
population characteristics at the baseline, inclusion and exclusion criteria for each study, sample 
size (participants, HF cases), outcome measures, diagnostic criteria for HF if mentioned, 
diagnosis measurements such as Framingham criteria and NYHA Classification to diagnose 
and categorized HF patients, number of men and women in each category, information 
regarding methodological quality and exposures definition, HF events, the relative risk and risk 
ratios (RR), hazard ratio (HR) for each group with 95% confident interval (95% CI) with their 
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p-value, and the co-variables in multivariable adjusted HR. These forms with summary of 
included studies are presented in Appendix 2 and Appendix 3.  
2.6 Data synthesis 
A meta-analysis was conducted when possible due to consistency of available data of included 
studies. For pooling the effect size from the studies in which clinical heterogeneity was 
observed, a random-effect model was applied. The RR for each group of studies with 95% 
confident interval (95%CI) and p-value were extracted. Heterogeneity among the included 
studies was investigated using Cochran’s Q test and 𝐼2  with a P value of <0.1 considered 
statistically significant (111). Publication bias was considered. Data syntheses were conducted 
using STATA software (Stata 15-Windows). The software was used to calculate the pooled RR 
and HR values and 95% CIs for risk of HF in relation to the exposures and show them in forest 
plots. The extent of heterogeneity was tested with 𝐼2 0%, 25%, and 75% representing low, 
medium, and high heterogeneity, respectively.  
2.7 Identifying and measuring heterogeneity 
The heterogeneity of studies and variability among studies was assessed with  𝐈𝟐 , and the 
overlap of the CIs in the forest plot graphs and whiskers. The statistical heterogeneity was 
assessed by checking the p value of  𝐈𝟐. Studies are regarded as homogeneous if CIs of all 
studies overlap and if  𝐈𝟐  was 40% or lower. (Figure 7) (112). When we observed high 
heterogeneity between studies (𝐼2) ˃ 80.0%, subgroup meta-analyses were reperformed across 
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𝐼2: (Ranges between 0 to 100%)                       Heterogeneity (= Diversity between studies) 
The importance of inconsistency of the results of studies due to 𝐼2 
0% to 40% 
30% to 60% 
50% to 90% 
75% to 100% 
might not be important 
may represent moderate heterogeneity 
may represent substantial heterogeneity 
considerable heterogeneity 
Figure 7 The magnitude and direction of the effects and the strength of evidence for heterogeneity such as p 
value from the chi-squared test, or a confidence interval for I2, explain the importance of the observed value of I2 
(111, 113) 
 
2.8 Measure of exposure effects and dealing with missing data 
2.8.1 Interpreting the HR 
The HR may also have been referred to as relative risk (RR). The measured outcome is 
dichotomous (HF event). Therefore: If the calculated RR or HR was > 1 this shows higher risk 
of HF in exposure group. If the calculated RR or HR was < 1 this shows reduced risk of HF in 
exposure group. 
2.8.2 Missing data 
For missing statistical data, an available case analysis was executed and important numbers for 
analyzing data were calculated: the percentage of women and men in each category, the 
prevalence of HF where it was applicable, the crude numbers from given percentage. 
The hazard ratios for each lifestyle factor are presented for one unit of the variable analyzed. 
The HF incidence rate for each study was calculated following this formula: 
Incidence rate = 
𝑁𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝑛𝑒𝑤 𝐻𝐹 𝑐𝑎𝑠𝑒
𝑃𝑜𝑝𝑢𝑙𝑎𝑡𝑖𝑜𝑛 𝑎𝑡 𝑟𝑖𝑠𝑘 ×𝑦𝑒𝑎𝑟𝑠
 × 105       
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3 Results 
The study selection process based on the literature search is shown in figure 8. The descriptions 
of included studies are available in table of “Characteristics of included studies” in appendix 2 
and appendix 3. The listed of excluded studies is available in appendix 4. 
3.1 Description of studies 
For the first step, a basic search was done with the total of 2007 obtained references by 
electronic search through CINHAL (n= 355), MEDLINE (n= 409), and EMBASE (n=1243). 
An advance search was then carried out obtaining a total 359 articles by electronic search 
through CINHAL (n=39), MEDLINE (n=195), and EMBASE (n= 125). All the obtained 
articles from the basic search and advanced searched were screened to identify relevant studies. 
Also a manual check of reference list of included papers has done which resulted in 47 articles.  
All the references (2413 articles) were screened by titles and abstracts. Of the retrieved articles, 
154 references were kept for possible inclusion. Assessment according to the inclusion criteria 
resulted in 46 eligible studies, of which 9 studies were finally included in the systematic review 
and meta-analysis. The flow diagram depicts the summary of the different stages of the 
systematic literature review (Figure 8). The list of excluded and included articles are available 
in appendix 2-4. 
Nine studies were finally included (seven articles on the effect of smoking, and six articles on 
the effect of physical activity) in the systematic review and meta-analysis. Four articles 
included data for both the effect of smoking and physical activity (2, 37, 103, 114). Three 
articles included data, only for effect of smoking (109, 115, 116). Two articles include data 
only for effect of physical activity (53, 117). One cohort from Finland contributes to three 
publications for the effect of physical activity (2, 53, 117). One cohort of UK contribute to 2 
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publications for the effect of smoking (103, 109). One publication consists of results from two 







Figure 8 Flow diagram depicting the different stages of study selection 
 
3.2 Results of the search 
3.3 Description of the participants 
3.3.1 Baseline characteristics of participants in studies assessing the 
effect of smoking 
For analyses of the influences of gender on the association of smoking and HF, seven studies 
were included (2, 37, 103, 109, 114-116) in the meta-analysis and systematic review according 
to eligibility criteria. Baseline in the cohort studies occurred in the 1960s and end of follow-up 
was at latest 2010. The four developed countries UK, USA, Finland and Sweden were the 
settings of the studies. Two population studies from UK (103, 109) used the same data sources 































Check for duplication of records 
 
154 articles with data retrieved according to 
the title and abstract 
 Full-text articles assessed for eligibility  
 9 articles included  
 
Reasons: 
- Not stratified by sex  
- No relevant outcomes 
- Case-control or cross-sectional  
- Not adjusted for age  
- Incomplete reported data 
145 Full-text articles excluded, with reasons 
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(CALIBER). Since their study aims, follow-up time and their inclusion/exclusion criteria were 
different, the number of participants and HF events differed in their studies. To avoid 
overestimation, studies from the same data sources are considered separately in each meta-
analysis. The baseline age of the participants was not restricted to a specific age group. The 
range of mean follow-up time was 5.5 to 19 years. At baseline, mean BMI of the included 
populations ranged from 23.2 to 29.1 kg/m2 for men and from 22.4 to 29.9 kg/m2 for women. 
A detailed summary of the baseline characteristics of participants in the included studies is 
shown in table 1 and table 2.  
3.3.1.1 Incidence rates of HF in studies to addressing the effect of smoking 
HF incidence rates differed between sexes and varied between studies. Overall, incidence rates 
were higher in men than in women except in the study of Alexander et al. (115), and in the study 
of Rodríguez et al. (109), in which, the HF events were higher in women. The highest incidence 
rate was observed for in the study of Uijl et al. (103) with HF incidence of 9.93 per 1000 
populations per year for men, and 9.1 per 1000 populations per year for women (Table 1). 
3.3.2 Baseline Characteristics of participants in studies assessing the 
effect of physical activity 
For analyses of the influence of gender on the association between physical activity and HF, 
seven cohort studies from six publications were included (2, 37, 53, 103, 114, 117) in 
accordance with the eligibility criteria and the availability of data. The cohort studies started in 
1972 and ended at latest in 2010. The four developed countries of UK, USA, Finland and 
Sweden were the setting of the studies. Three population studies (2, 53, 117) used the same data 
sources (FINRISK study). Since their study aims, follow-up time, and their inclusion/exclusion 
criteria were different, the number of participants and HF events differed in those studies. To 
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avoid overestimation, studies from the same data sources are considered separately in each 
meta-analysis. The baseline age of the participants was not restricted. The range of mean 
follow-up time was 5.8 to 19 years. Mean baseline BMI ranged from 23.2 to 29.1 kg/m2 for 
men and from 22.4 to 29.9 kg/m2 for women. Participants engaging in ≥150 minutes of physical 
activity per week were considered physically active, which is consistent in all included studies, 
and at least 5.3% of participants were physically active at baseline. A summary table of baseline 
characteristics of participants in included studies on physical activity and HF is available in 
table 3 and table 4. 
3.3.2.1 Incidence rates of HF in studies addressing the effect of physical 
activity 
HF incidence rates differed between genders and varied between studies. Overall, incidence 
rates were higher in men than in women. The highest incidence rate was observed in the study 
by Uijl et al. (103) from UK with HF incidence of 9.93 per 1000 populations per year for men 
and 9.1 per 1000 populations per year for women (Table 3).  
 
Additional data from the studies were sourced for in the articles and are summarized in tables 
1-4. 
  
3.4 Effect of the exposures and outcome 
We present the results of the studies as shown in tables 5-8 and plots in graph 1 and 6. All 
studies estimated the effect of physical activity and smoking on HF by HR or RR from cox 
proportional hazards regression analyses. 
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Table 1. Baseline characteristic of studies for investigating the effect of smoking on risk of HF. Part 1 
 Authors Year Country Study name Participants Mean years of follow-
up 
HF cases Incidence rate 
Per 1000 population 
Age range 
of participants 
Men Women Men Women Men Women 
1. Alicia Uijl (103) 2019 UK CALIBER 871 687 5.8 47 987 9.49 ≥ 55 y/o 
404 645 467 042 23 314 24 673 9.93 9.1 
2. Jiang He (37) 2001 USA NHANES 1 13 643 19 1 382 5.33 1 – 74 y/o 
5 545 8 098 741 641 7.33 4.16 
3. Yujie Wang 
(2) 
2011 Finland FinRisk 38 072 14.1 1 083 2.02 25 –74 y/o 
18 346 19 726 638 445 2.46 1.6 
4. Mark Alexander 
(115) 
1995 USA HMO 57 842 9.5 1 330 2.42 ≥40 y/o 
27 708 30 134 618 712 2.34 2.48 
5. Mar Pujades-
Rodriguez (109) 
2014 UK - 1 937 360  5.5 14 359 1.34 ≥ 30 y/o 




2009 USA - 2 934 7.1 258 12.38 70 – 79 y/o 
1 405 1 529 140 118 14.03 10.86 
7. Susanna C. 
Larsson (118) 
2016 Sweden COSM & 
SMC 
64 679 13 2 584 3.07 45 – 83 
33 966 30 713 1 488 1 096 3.36 2.74 
Total 2 986 217  68 983 
1 449 944 1 536 273 33 145 35 838 
 
Table 2Baseline characteristic of studies for investigating the effect of smoking on risk of HF. Part 2  
 Authors Women 
(%) 
Categories Physically active (% ) Mean Age (y/o) Mean BMI (kg/m2) Smokers (%) 
men women men women men women men women 
1. Alicia Uijl (103) 53.58 Age: 55-64 y 56.5 47.2 - - 28.5 29.8 32.4 26.2 
Age: 65-74 y 51.9 39.7 - - 27.3 28.1 19.7 16.5 
Age: ≥75 y 37.7 24.5 - - 25.7 25.5 12.5 7.3 
2. Jiang He (37) 59.36 - 63 51 52.2 48.1 25.7 26.6 40.7 31.1 
3. Yujie Wang 
(2, 114) 
51.82 No. healthy factor: 0 0.0 0.0 47.5 44.9 29.1 29.9 100 100 
No. healthy factor: 1 16.7 5.3 48.2 48.8 27.8 28.9 53.8 41.5 
No. healthy factor: 2 41.8 19.9 47.2 47.8 26.9 27.1 28.3 21.5 
No. healthy factor: 3 70.2 52.7 44.3 44.0 25.3 24.5 11.5 8.9 
No. healthy factor: 4 100 100.0 41.4 41.0 23.2 22.4 0.0 0 
4. Mar Pujades-Rodriguez (109) 58.82 All with smoking data - - 46.0 47.9 26.7 26.1 23.64 17.50 
Missing smoking data - - 45.4 50.9 27.3 26.7 - - 
5. Andreas Kalogeropoulos (116) 52.1 - - 73.6 27.3 10.5 
6. Susanna C. Larsson (118) 47.48% - 77 73 59.3 60.9 26 25 24 23 
7. Mark Alexander (115) 52.10 African-American Without CHF - 51.7 - 59.8 
With CHF - 59.8 - 63.5 
White Without CHF - 55.4 - 56.7 
With CHF - 67.4 - 59.1 
 
Table 3 Baseline characteristic of studies for investigating the effect of physical activity on risk of HF. Part 1 
No Authors Year Country Study name Participants Mean 
years of 
follow-up 
HF cases Incidence rate 
Per 1000 population 
Age range of 
participants 
Men Women Men Women men women 
1. Alicia Uijl (103) 2019 UK CALIBER 871 687 5.8 y 47 987 9.49 ≥ 55 y/o 
404 645 467 042 23 314 24 673 9.93 9.1 
2. Jiang He (37) 2001 USA NHANES 1 13 643 19 y 1 382 5.33 1 – 74y/o 
5 545 8 098 741 641 7.33 4.16 
3. Yujie Wang 
(2) 
2011 Finland FinRisk 38 072 14.1 y 1 083 2.02 25 –74 y/o 
18 346 19 726 638 445 2.46 1.6 
4. Gang Hu (117) 2010 Finland FinRisk 59 178 18.4 y 3 614 3.32 24 – 74y/o 
28 842 30 336 1 921 1 693 3.62 3.03 
5. Yujie Wang (53) 2010 Finland FinRisk 58 208 18.4 y 3 508 3.27 25 – 74y/o 
28 334 29 874 1 868 1 640 3.58 2.98 
6. Susanna C. Larsson 
(118) 
2016 Sweden COSM & SMC 64 679 13 y 2 584 3.73  
45 – 83y/o 33 966 30 713 1 488 1 096 3.36 2.74 
Total 1 105 467  60 158 
519 678 585 789 29 970 30 188 
 
Table 4 Baseline characteristic of studies for investigating the effect of physical activity on risk of HF. Part 2 
No Authors Women(%) categories Physically active (% ) Mean Age (y/o) Mean BMI (kg/m2) Smokers (%) 
men Women men women men women men women 
1. Alicia Uijl (103) 50.75 Age: 55-64 y 56.5 47.2 - - 28.5 29.8 32.4 26.2 
Age: 65-74 y 51.9 39.7 - - 27.3 28.1 19.7 16.5 
Age: ≥75 y 37.7 24.5 - - 25.7 25.5 12.5 7.3 
2. Jiang He (37) 59.36 - 63 51 52.2 48.1 25.7 26.6 40.7 31.1 
3. Yujie Wang 
(2) 
51.82 No. healthy factor: 0 0.0 0.0 47.5 44.9 29.1 29.9 100 100 
No. healthy factor: 1 16.7 5.3 48.2 48.8 27.8 28.9 53.8 41.5 
No. healthy factor: 2 41.8 19.9 47.2 47.8 26.9 27.1 28.3 21.5 
No. healthy factor: 3 70.2 52.7 44.3 44.0 25.3 24.5 11.5 8.9 
No. healthy factor: 4 100 100.0 41.4 41.0 23.2 22.4 0.0 0. 
4. Gang Hu (103, 
117) 
51.26 - 61.8 60.0 45.0 45.0 26.4 26.4 41.1 18.0 
5. Yujie Wang (53) 51.32 Occupational physical activity 
 
Low - - 48.5 46.8 26.5 26.0 41.8 19.3 
Med - - 42.2 42.4 26.4 25.7 36.6 18.7 
High - - 43.0 44.2 26.3 26.6 43.2 16.3 
Commuting Physical Activity Low - - 46.2 47.1 26.5 26.5 45.3 18.3 
Med - - 42.2 42.1 26.3 25.8 38.1 19.0 
High - - 46.0 43.9 26.1 25.6 39.6 17.7 
Leisure-Time physical Activity Low - - 45.5 45.7 26.7 26.9 50.0 21.6 
Med - - 46.3 45.2 26.5 25.8 41.8 17.8 
High - - 41.0 41.3 25.7 25.0 27.8 12.4 
6. Susanna C. 
Larsson (118) 
47.48% - 77 73 59.3 60.9 26 25 24 23 
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Table 5 Smoking and risk of HF in women 
Author Year Country Study 
name 
























1.33 1.18 1.49 Never smoker 
65 – 74 y/o 1.21 1.11 1.32 
≥75 y/o 1.08 0.99 1.19 
 
Jiang He (37) 








1.88 1.53 2.30 Never and ex-smoker, 
p < 0.001 
 
 
Yujie Wang (2) 










2.09 1.59 2.74 Never smoker, 
p for trend < 0.001 
 
 
Mark Alexander (115) 









n for CHF 
Multivariate 
RR 
1.64 1.12 2.39 Non-smoker, (Smoked 


















1.77 1.47 2.13 Never smokers, 























0.85 3.32 Never and ex-smoker, 
p  = 0.87 
White 2.72 1.17 5.64 p  = 0.22 












0.63 0.54 0.73 - 
uCI: upper confidence interval, lCI: lower confidence interval, HR: hazard ratio, RR: relative risk, risk ratio  
Table 6 Smoking and risk of HF in men 
Author Year Country Study 
name 
Study design Statistical test Exposure
, 
Endpoint 


















Multivariate HR 1.27 1.14 1.40 Never smoker 
65 – 74 y/o 1.15 1.07 1.24 
≥75 y/o 1.05 0.95 1.16 







Multivariate RR 1.45 1.24 1.70 Never and ex-smoker 
p <0.001 









Multivariable HR 1.86 1.51 2.30 Never smoker, 
p for trend < 0.001 












Multivariate RR 2.18 1.46 3.25 Non-smoker, (Smoked 
≤ 1 year) 
Mar Pujades-Rodriguez 
(109) 











Age adjusted HR 1.57 1.47 2.13 Never smokers, 


















1.88 1.01 3.35 Never and ex-smoker, 
p = 0.87 
white 1.32 0.42 3.21 Never and ex-smoker, 
p  = 0.35 












Multivariable RR 0.75 0.71 0.79 - 
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Study design Statistical test Exposure, 
endpoint 







55 – 64 y/o 2019 UK UK-based 
CALIBER 






1.09 1.00 1.19 Physical active 
65 – 74 y/o 1.09 1.01 1.17 
≥75 y/o 1.08 1.02 1.15 





adjusted for some 
variables 
1.34 1.15 1.58 Physical active 
 
p < 0.001 
Multivariate RR 1.31 1.11 1.54 p = 0.002 









Multivariable HR 0.64 0.48 0.86 Light physical 
active, 
P for trend= 
0.009 







adjusted for age 
and study year 
0.54 0.47 0.61 Low physical 
activity, 
𝑝𝑡𝑟𝑒𝑛𝑑 < 0.001 
Multivariate 
adjusted HR 
0.68 0.59 0.78 𝑝𝑡𝑟𝑒𝑛𝑑 < 0.001 







Adjusted for some 
covaraibles 
0.74 0.59 0.92 Low physical 
activity 
𝑝𝑡𝑟𝑒𝑛𝑑 < 0.001 
Adjusted for more 
covaraibles 
0.75 0.60 0.94 𝑝𝑡𝑟𝑒𝑛𝑑 = 0.001 








Multivariable RR 0.71 0.63 0.81 - 
uCI: upper confidence interval, lCI: lower confidence interval, HR: hazard ratio, RR: relative risk, risk ratio  
 
 
Table 8 Physical activity and risk of HF in men 
Author Year Country 
/Reports 








95%lCI 95%uCI Reference group 
Alicia Uijl 
(103) 










1.06 0.99 1.13 Physical active 
65 – 74 y/o 1.11 1.04 1.17 
≥75 y/o 1.09 1.02 1.16 














for all listed 
Co-variables 
1.14 0.94 1.38 p = 0.19 













0.67 0.53 0.86 Light physical 
activity, 
p for trend= 
0.006 










age and study 
year 
0.75 0.66 0.86 Low physical 
activity 
𝑝𝑡𝑟𝑒𝑛𝑑 < 0.001 
Multivariate 
adjusted HR 
0.86 0.75 0.99 𝑝𝑡𝑟𝑒𝑛𝑑 < 0.001 












0.66 0.55 0.79 Low physical 
activity 




0.65 0.54 0.77 𝑝𝑡𝑟𝑒𝑛𝑑 < 0.001 












0.83 0.74 0.94 - 
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3.4.1 Effect of smoking 
 
According to the results of the included studies, the risk of HF among smoker is higher than 
non-smokers with higher risk increase in smoker-women than in smoker-men.  
In seven of ten studies, smoking has stronger effect on HF risk in women than in men; only in 
two reports from US studies (115, 116) smoking has stronger effect on HF in men (116) and 
this occurred in African-American population and the effect size was unadjusted (Graph 1). 
Graph 1 Forest plot showing HR [95% CI] for HR in relation to of risk factors stratified by gender from included 
studies in the review. The gray squares indicate the weights allocated to each reports based on precision of the 
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Adjustment variables included in the regression models in each study are summarized in table 
9. Adjustment in the studies differed, however, the variables that were most frequently included 
were age, race/ethnicity, BMI, SBP, hx of MI, hx of DM, and hx of VHD. 




























































































































Uijl (103)  × ×  ×  ×      × ×  AF, Social deprivation, lipid regulating medication, COPD, Hb, WBC, 
Creatinine, DBP, stratified by age 
He (37) × × × × × ×  × × ×  × × × × Cholesterolemia 




















  Vegetable and fruit consumption, Anti HTN 
Larsson (114) × 
 




    × 
 
  AF, all other healthy lifestyle factors, HTN 














    Serum Uric Acid, serum creatinine, proteinuria 










   × 
 
  Index of multiple Deprivation, HRT, OCP, DBP, WBC, Hb, Creatinine, 
Alanine transferase, baseline medication on for liver disease, COPD, cancer, 
renal disease, depression  
Kalogeropoulos (116)                Unadjusted RR reported 
 
According to the adjustment performed, we selected seven reports from five articles for meta-
analysis (2, 37, 103, 109, 115). One reports were excluded from the meta-analysis due to 
unadjusted models (116), and 1 report was excluded due to estimation of HR for noncurrent 
smoker and not for smoker (114). The risk of HF was significantly higher among smokers than 
non-smokers, both overall and among women and men separately (Table 10, Graph 2 and 3). 
 
Table 10 The estimated effect size of smoking on risk of HF  
 Pooled Effect 
size, 95%CI 
𝐼2 ρ  
Women 1.23 (1.17-1.29) 85.6% <0.0001 
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Graph 2 Forest plot showing HR [95% CI] for HF in relation to smoking status in women. The gray squares 
indicate the weights allocated to each reports based on precision of the 95%CI.the Black vertical line shows 1. 
 
Graph 3 Forest plot showing HR [95% CI] for HF in relation to smoking status in men. The gray squares indicate 
the weights allocated to each reports based on precision of the 95%CI, the Black vertical line shows 1. 
 
weight HR [95% CI] 
weight HR [95% CI] 
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We observed heterogeneity between the studies (I² ˃ 80.0%). Sub-group analyses were 
conducted between the studies to explore the observed heterogeneity. Meta-analysis between 
the studies of Wang (2), He (37), Alexander (115), and Rodriguez (109) shows no evidence of 
heterogeneity in the final model (Table 11, Graph 4 and 5) 
Table 11 The effect of smoking on risk of HF according four studies (2, 37, 109, 115) 
 Pooled Effect size, 
95%CI 
𝐼2 ρ  
Women 1.83 (1.62, 2.05) 0.0% 0.725 
Men 1.58 (1.41, 1.75) 38.6 % 0.180 
 
 
Graph 4 Forest plot showing HR [95% CI] for HF in relation to smoking status in women, according four studies 
(2, 37, 109, 115). The gray squares indicate the weights allocated to each reports based on precision of the 





weight HR [95% CI] 
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Graph 5 Forest plot showing HR [95% CI] for HF in relation to smoking status in men according four studies (2, 
37, 109, 115). The gray squares indicate the weights allocated to each reports based on precision of the 95%CI, 
the Black vertical line shows 1. 
 
 
3.4.2 Effect of physical activity 
For assessing the effect of physical activity, data from six articles (2, 37, 53, 103, 114, 119) 
with 1,105,467 individuals were available for the analysis, in whom there were at least 60,158 
fatal and non-fatal HF events. Three articles based on the FINRISK study (2, 53, 117) reported 
HF events from the same data source and therefore the actual number of events could not be 
precisely determined. The prevalence of physical activity was varied in different subcategories 
of included populations. In all studies, the prevalence of physical activity was higher in men 
than in women. All studies reported results as multivariate HR. Adjustment variables that each 
study used in their model to adjust the final ratios are summarized in table 12. Adjustment 
differed between studies, however, the variables that were most frequently included were age, 
race/ethnicity, smoking, BMI, SBP, hx of MI, hx of DM, and hx of VHD. In one study, the 
weight HR [95% CI] 
 
Page 31 of 97 
outcome was CHF. Detection of HF cases is described in appendix 3. All extracted information 
on adjusted HRs or RRs with related statistical tests, exposure and outcome, and references 
group is summarized in table 7 and 8. The plot in figure 6 shows a summary of estimated effects 
of physical activity on HF.  

















































































































Uijl (103)  × ×  ×   × ×      × × AF, Social deprivation, COPD, Hb, WBC, Creatinine, DBP, stratified by age 
He (37) × × × × × × ×   × × ×  × × ×  
Wang 2011 (2) ×  ×  ×  × ×  × × × ×  × × Fruit & vegetable consumption  
Larsson (114) ×      ×   ×     ×  Family hx of HTN, AF, all healthy life style factors 
Hu (117) ×  ×  ×  ×   × × × ×  × ×  
Wang 2010 (53) ×  ×  ×  × ×   × × ×  × × Lung disease, other types of physical activities 
 
Graph 6 Forest plot showing HR [95% CI] for HF in relation to physical activity startified by sex. The gray squares 
indicate the weights allocated to each reports based on precision of the 95%CI, the Black vertical line shows 1. 
 
 
weight HR [95% CI] 
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Uijl et al. (103) analyzed data from the UK-CaLIBER study to assess the effect of physical 
activity on HF. They used the physically active group as reference group (HR=1). They 
staratified by age into three subcategories of 55-64, 65-74 and ≥75 years old. However, they 
adjusted the HR for age, race, history of used BP lowering medication and lipid regulating 
drugs. The HR with 95% CI was 1.09 (1.05, 1.13), 𝐼2= 0.0%, p= 0.589 for men and 1.09 (1.04, 
1.13), 𝐼2= 0.0%, p= 0.976 for women (Figure 9, graph 7 and 8). The result was homogenous 
but insingnificant for trend. The authors found a stronger effect on HF for smoking than 
physical inactivity (Figure 9). Furthermore, their results showed that it was a stronger effect of 
smoking and sedentary life style on HF in women than in men. 
 Figure 9 Comparing the effect of physical inactivity and smoking according to 
the study of Uijl et al.  (103) 
 
 
Graph 7 The pooled estimated effect of smoking in women according the study of Uijl et al. (103). The gray 






Sedentary life style effect, RR= 1.09 
The effect of sedentary life style on development of HF according to the 
study of Uijl et al.  
 Pooled Effect 
size, 95%CI 
𝐼2 ρ value 
Total 1.09 (1.06-1.12)  0.0% 0.953 
 
 
The effect of smoking on development of HF, according to the study 
of Uijl et al.                      
 Pooled Effect 
size, 95%CI 
𝐼2 ρ value 
 Total 1.16 (1.11-1.20) 66.6% 0.011 
           
 
 
weight HR [95% CI] 
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Graph 8 The pooled estimated effect of smoking in men according the study of Uijl et al. (103). The gray squares 
indicate the weights allocated to each reports based on precision of the 95%CI, the Black vertical line shows 1. 
 
 
The NHANES I study (37) investigated the effect of low physical activity on CHF. They 
defined the physically active group as reference group (RR=1). The RR (95% CI) for men was 
1.14 (0.94, 1.38), p= 0.19 and for women was 1.31 (1.11, 1.54), p= 0.002. Risk of HF in relation 
to physical inactivity was stronger for women than men. They found a stronger effect on HF 
risk for smoking than for low physical activity (Figure 9).  






Three articles of Finland (2, 53, 117), from the same data source of FINRISK, were published 
in 2010 and 2011. One article investigated the relationship between physical activity and HF 
RR= 1 Smoking effect 
RR= 1.49 
Low physical activity 
effect 
RR= 1.33 
The effect of low physical activity on HF incident 
 RR, 95%CI ρ value 
Total 1.33 (1.19-1.49)  <0.0001 
 
 
The effect of smoking on of HF incident                        
 RR, 95%CI ρ value 
 Total 1.49 (1.30-1.70) <0.0001 
           
 
 
HR [95% CI] weight 
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(117). Two other articles subcategorized physical activity according to leisure-time physical 
activity, commuting physical activity, and occupational physical activity (2, 53). All three 
articles considered low physical activity as reference group (HR=1). Two reports showed a 
stronger protective effect of physical activity on HF risk in women, while one article reported 
a stronger protective effect of physical activity in men (RR= 0.75 in women vs RR= 0.65 in 
men). The pooled HR effect size of physical activity from three FINRISK articles show stronger 
protective effect of physical activity for women in than in men (Table 13).  
 
Table 13 The effect of high physical activity on development of HF. The three studies (2, 53, 117) of Finland with 
the same data sources. 
 Pooled Effect 
size, 95%CI 
𝐼2 ρ value 
Total 0.71 (0.66-0.76) 40.4% 0.136 
Women 0.69 (0.61-0.76) 0.0% 0.676 
Men 0.73 (0.66- 0.81) 70.9% 0.032 
 
Those three article from FINRISK (2, 53, 117) compared the effect of current smoking and high 
physical activity on the risk of HF. The increased risk of HF for current smokers was greater 
than the risk reduction from physical activity (Figure 11). They found a stronger effect of 
smoking and physical activity on HF risk in women than in men.  








An article based on Swedish COSM and SMC study (114) reported the effect of physical 
activity on HF events, adjusted for education, family hx of hypertension, hypercholesterolemia, 
RR= 1 Non-current smoking effect 
RR= 0.73 
Physical activity effect, RR= 0.66 
The effect of high physical activity on HF event  
 Effect size, 
95%CI 
𝐼2 ρ  
Total 0.66 (0.53-0.78)  0.0% 0.815 
  
 
The effect of current smoking on HF event                        
 Pooled Effect 
size, 95%CI 
𝐼2 ρ  
 Total 1.93 (1.61, 2.26) 0.0% 0.518 
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diabetes mellitus, AF, and all healthy lifestyle factors simultaneously in the same model. They 
found a stronger protective effect of non-current smoking than physical activity on HF risk 
(Figure 12). Moreover, they found a greater protective effect of non-current smoking and 
physical activity on HF risk in women than in men. (RR: 0.71 (0.63, 0.81) for women vs RR: 
0.83 (0.74, 0.94) for men).  







3.5 Risk of Bias in included studies  
The risk of bias summary is available in table 14 for studies assessing the effect of smoking and 
in table 15 for studies assessing the effect of physical activity. All domains of bias were 
evaluated for each included study. The supplementary information about assessing each domain 
of bias for studies are presented in appendix 2 and 3.  
3.5.1 Selection bias (selection of exposed non-exposed cohorts) 
All studies were large population cohort studies. The study of NHANES I (37), oversampled a 
certain population of low income, women of childbearing age, and elderly. The study of 
Kalogeropoulos et al. (116) sampled from the insured population. Except these two 
aforementioned studies, in other studies there were no systematic differences, overrepresented 
or underrepresented between baseline characteristics of the groups that are compared which 
may lead to either an overestimation or underestimation of the association between exposure 
RR= 1 
Non-current smoking effect 
RR= 0.73 
Physical activity effect 
RR= 0.83 
The effect of physical activity on HF event  
 Pooled Effect 
size, 95%CI 
𝐼2 ρ  
Total 0.76 (0.70-0.83)  67.3% 0.080 
  
 
The effect of non-current smoking on HF event                        
 Pooled Effect 
size, 95%CI 
𝐼2 ρ  
 Total 0.73 (0.70-0.77) 80.0% 0.023 
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and risk of HF. The exposed and unexposed groups were drawn from the same population and 
from the same administrative data bases in a same time frame. So, they were considered of 
being at low risk of selection bias. The proportions of women varied from to 47.8% to 58.82% 
in studies assessing the effect of smoking, and from 47.48% to 59.36% in studies assessing the 
effect of physical activity. Age range of participants were from 24 years with a similar mean 
age range for men and women except in the study of Larsson et al. (114) where mean age of 
men and women at baseline differed. Other factors at baseline such as BMI, smoking and 
physical activity, were also considered for assessing the selection bias among studies.  
3.5.2 Performance bias (assessment of exposure)  
All the studies provided information how their data were obtained. Studies used secured record 
achieved by interview or questionnaire asking about the exposure. Studies used self-reported 
data and individual were asked for the exposure and may be subject to the risk of recall bias. 
except NHANES I study (37) in which the validity of information for smoking exposure have 
been presented and shows 85% to 95% validity (120, 121). The study of Wang et al. (53) 
checked the information of physical activity. They have has shown a high correlation with 
physical fitness, as measured by maximal oxygen uptake. In the included studies it was not 
clear if the people who participated in acquiring data in the retrospective studies and the 
participants were blind to the research aim while they answered the questioners or not. 
3.5.3 Detection bias  
The outcome of interest (HF incident) was obtained from medical records which is sufficient 
for certainty and validity but might vary somewhat from hospital to hospital and between 
countries. The follow-up time considered long enough to have observed effect size. Data were 
collected from data base with documentation of accuracy of prognostic data. The criteria and 
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validity of diagnosis for FINRISK study and CALIBER study were mentioned in their studies 
(2, 103), and for NHANES I elsewhere (122). The validity of HF detection were checked with 
BNP level, echocardiographical findings, and prescribed medications. For each article 
comprehensive matching and statistical analysis adjustment for prognostic variables had been 
done except for the study of Kalogeropoulos (116). In the study of Kalogeropoulos (116), there 
were no deaths from incident HF because HF was not allowed as a cause of death.  
3.5.4 Attrition bias (incomplete outcome data) 
In one study (109) they started with 5,372,790 participants and ended up with 1,937,360 due to 
their inclusion and exclusion criteria. One study (115) the number of patients with incomplete 
data in the groups was not reported, so these two studies were judged to contain a high risk of 
attrition bias. In other studies, as the reasons of the exclusions are stated and the number of 
excluded people was balanced between the groups, and missing data have been included using 
an appropriate method, the study was judged to be at low risk of attrition bias.   
3.5.5 Reporting bias (selective reporting) 
It was not possible to assess if the outcomes specified in the protocol were reported since 
protocols were not available for the studies. 
3.5.6 Other potential sources of bias 
Studies have declared the source of funding. The differences in the participants’ characteristics, 
including co-morbidities, between subgroups were not significant in the reviewed studies. 
There is difference in the considered range of BMI for overweigh and obese. In the study of He 
et al. (37) overweight was BMI ≥ 27.8 for men, and ≥ 27.3 for women, while in study of  Larsson 
et al. (114) 18.5≤ BMI ≤ 25 kg/m2 was considered normal healthy weight. The study of Wang 
et al. (2) defined BMI as 20-25 kg/m2 for normal weight, 25 to 29.9 kg/m2 for overweight, and 
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≥30 kg/m2 for obese. The studies collected their data from different sources and each had their 
own measurement error, which increase the risk for measurement error and/or misclassification. 
Follow-up participants were passive rather than active. It was not clear how electrocardiography 
and echocardiography were undertaken and the results judged, and how left ventricular 
dysfunction were studied. They collected data once at the baseline, and it might possible that a 
person changes life style during the follow-up time. There are some unmeasured factors such 
as OCP or HRT. Pregnancy and lactation interfere in physical activity or smoking behavior 
which none of the selected studies mentioned to this. Using insured population could cause bias 
in the outcomes due to selection of a population with secure economy.  
Table 14 Summary of the risk of bias for each included study for investigating the effect of smoking and heart 




























































Uijl 2019 (103) - + - - ? + 
He 2001 (37) + - - - ? + 
Larsson 2016 (114) - + - - ? + 
Wang 2011 (2) - + - - ? + 
Alexander 1995 (115) - + - + ? + 
Pujades-Rodriguez 2009 (109) - + - + - + 
Kalogeropoulos 2009 (116) + + + - ? + 
 
Table 15 Summary of the risk of bias for each included study for investigating the effect of physical activity and 




























































Uijl 2019 (103) - + - - ? + 
He 2001 (37) + + - - ? + 
Larsson (114) - + - - ? + 
Wang 2010 (53) - - - - ? + 
Hu 2010 (117) - + - - ? + 
Wang 2011 (2) - + - - ? + 
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3.6 Publication Bias 
Seven articles were reviewed to assess the effect of smoking and six articles were reviewed to 
assess the effect of physical activity. For fewer than ten articles in the meta-analysis, tests for 
funnel plot asymmetry should not be used due to low test power to distinguish chance from real 
asymmetry. In particular, when there is a high level of heterogeneity, more than ten articles is 
needed to obtained meaningful results from testing funnel plot symmetry (123). Therefore, the 
funnel plot for assessing publication bias was not constructed due to insufficient number of 
studies and high level of heterogeneity that we observed between studies. Egger’s test was not 
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4 Discussion  
4.1 Summary of findings 
The current thesis reviewed nine studies to examine to what extent the association between 
smoking and physical inactivity and risk of HF differ among men and women.  
As expected, we observed that no-smoking and physical activity were each associated with a 
significant lower risk of incident HF in both men and women.  
Four studies (2, 37, 103, 114) revealed that both smoking and physical inactivity increased the 
risk of HF, and the effect of smoking was stronger than physical inactivity for risk of HF (2, 
37, 103).  
According to our review, smoking increased the risk of HF more in women than in men (2, 37, 
103, 109, 114, 116). Similarly, engaging in high physical activity reduced the risk of HF more 
in women than in men (2, 37, 114, 117).  
Two articles (53, 103) found an interaction between gender and the influence of physical 
activity on HF within different age groups, and for different subgroups of physical activity types 
(occupational, commuting, and leisure-time physical acuity).  
The study (53) that subcategorized physical activity into three types consisting of commuting, 
leisure time and occupational, found that engaging in high level of leisure-time physical activity 
was significantly more effective in men than in women, while their results showed engaging in 
high level of commuting physical activity had greater risk reduction in women than in men 
even after adjusting for two other types of physical activity.  
4.2 Overall completeness and applicability of evidence 
These findings should be interpreted with caution due to potential residual confounding of other 
HF risk factors. Adjustment of results for additional risk factors (e.g. CAD, MI, AF, VHD, high 
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fat diet, age, HTN) varied in included studies considerably. As shown in figure 13 and figure 
14, there are many modifiers involved in the casual pathway between smoking and physical 
activity and development of HF. The risk reduction of HF associated with physical activity and 
non-smoking may be mediated through prevention of HTN and CHD which are known as major 
risk factors of HF (37). Other conditions such as VHD, MI, and AF may represent other 
situations with acute and chronic damage to the heart muscles that can affect the cardiac output 
and result in HF development (13).  
Smoking affects HF risk through different mechanisms as is shown in figure 14. One important 
factor, which can cause gender differences in effect of smoking, is influence on estrogen level 
(124). Among studies assessing the effect of smoking, only one study (109) considered using 
OCP and HRT as a cofactor and reported adjusted result for OCP and HRT. Other studies did 
not mention information regarding HRT and OCP. The relationship between smoking and HF 
development remained even after adjustment for other HF risk factors suggesting additional 
underlying mechanisms contributing to HF development. 
Physical activity is a common and accessible mean for improve health among adults (125). In 
this thesis, physical activity is observed to reduce the risk of HF. In addition, the magnitude of 
this association was stronger in women. These findings suggest the potential contribution of 
gender in the preventive mechanism of physical activity, a finding which can be important for 
public health implications. Physical activity can mediate its risk reduction by reducing the HTN 
or regulate the body composition and BMI. Although, even after adjusting for factors e.g. BMI, 
overweight, and BP, physical activity remains as a preventive factor for HF.      
From the point of view for public health policy makers and healthcare providers, highlighting 
the modifiable risk factors for HF, is important when preventive strategies are planned. People 
who abstinence from smoking and engaging in high level of physical activity are substantially 
less likely to develop HF with a stronger effect for women. From the point of view for the 
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researcher, the association between smoking and physical activity with HF, even after adjusting 
for known risk factors (e.g. age, race, sex/gender, MI and HTN) suggests the possibility of 
other, not yet acknowledged underlying mechanisms for HF development. Thus, the results 
might inspire further mechanistic research into the physiology and pathophysiology. A better 
understanding of the relationship between gender differences in the association between 
lifestyle factors and HF will ultimately improve the QOL for both men and women. 
 
 
    
Figure 13 A schematic description of possible relationship between physical activity and heart failure (right side of 
the picture) with potential mechanisms through which physical activity contribute to heart failure risk reduction (left 
side of the picture) (126) 
Physical activity directly or through the benefits of 
fitness, may reduce the risk of HF  
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Figure 14 Various pathophysiological mechanisms stimulated by  smoking tobacco potentially  promoting  heart 
failure development (51, 127) 
 
4.3 Quality of the evidence 
According to the assessment of risk of bias, the included studies present high quality studies, 
however, they were not free of bias. Self-reported data were collected for exposures and other 
cofactors such as alcohol consumption and diet.  
The study of Uijl et al. (103) chose a population older than 55 years from four different ethnicity 
subcategories which were Caucasians, black, Asian, and other. Their first endpoint was incident 
HF. To define HF, they used two different data sources with their own measurement error. So, 
the risk of measurement error and/or misclassification exists in their study. They did not 
mention dose of smoking (e.g. pack/year). They categorized their participants as never, current, 
and ex-smoker (quit < 2y, 2-5 y, 5-10 y, ˃10y). For investigating physical activity, two 
subcategories of sedentary life style or active life style were defined without complementary 
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information for quality or type of physical activity. The participants were stratified by age 
which reduced the confounding effect of age. The validity of HF detection was checked in the 
record with LV dysfunction confirmed by cardiac imaging, an elevated BNP concentration, 
referral to HF care, referral to a cardiologist, the use of loop diuretics, and symptoms and signs 
suggestive of HF (128).  
The other study (109) from CALIBER study, started with 5,372,790 participants and after 
exclusion ended up in 1,937,360 participants. They classified smokers in groups of: never 
smoker, ex-smoker, and current smoker. Ex-smokers were grouped into categories of time since 
quitting to < 2 years, 2-5 years, 5-10 years, ˃10 years and missing.  
The study of He et al. (37) used a large cohort sample but oversampled certain population 
subgroups (those with a low income, women at childbearing age, and elderly). They used self-
reported information with a passive follow-up rather than active follow-up. They did not 
provide information for dose of smoking and physical activity and only categorized participants 
to subgroups of non-smoker vs current-smoker and low physical activity vs high physical 
activity. The validity and reliability of surrogate information on smoking data were checked 
and estimated to 85% to 95% (121). Detecting HF patients was done based on obtaining hospital 
records, pathology reports, electrocardiograms, and death certificates (122).  
The study of Larsson et al. (114) consists of two cohort studies with a large sample with a mean 
follow-up time of 13 years. The data collected was based on self-reported questionnaire which 
increase the risk of recall bias. Their information for smoking and physical activity did not 
detail doses. However, the incident of HF were obtained by National Patient Register and the 
Swedish Cause of Death Register with the validation of 95% of primary HF diagnosis.  
The articles of FINRISK study (2, 53, 119) used a large sample of cohort population of five 
independent cross-sectional surveys, which might increase the risk of measurement error and/or 
misclassification. The data on exposures were collected with self-reported questionnaire with 
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the risk of recall bias. The questionnaires were mailed to participants and the follow-up was 
passive rather than active. While the information of smoking was categorized as never, ex and 
current smoker without more details of dose and duration, a comprehensive information of 
physical activity was collected. The questionnaire used for the assessment of physical activity 
has shown a high correlation with physical fitness, as measured by maximal oxygen uptake 
(53). However, the exposure data was collected only once during the follow-up without 
information of data on possible changes on lifestyle factors during follow-up. The validity of 
HF detection in FINRISK study was more than 80% based on the European Society of 
Cardiology definition (53).  
The study of Alexander et al. (115) used a cohort of insured population. They collected medical 
and social history with self-reported questionnaire, and a series of clinical laboratory tests, chest 
x-rays, electrocardiogram, and an examination record provided by a physician. They did not 
mention the number of participants that were excluded or the dose of smoking. Smoking was 
defined as smoked more than 1 year and other as non-smoker.    
The health ABC study of USA (116) collected data based on self-reported history with no 
deaths from incident HF because HF was not allowed as a cause of death in the death registry.  
4.4 Potential biases in the review process 
Observed different results in the included studies might be due to varying follow-up time, 
diversity in study population or quality of data, and regional/cultural differences. However, 
each study we reviewed, have reported adjusted results for some co-variables such as education, 
alcohol consumption, diet, and age (Table 9 and Table 12). The bio-psycho-social variation in 
a sample of different studies, across different places and times may determine whether gender 
differences in the effect of physical activity and smoking meet criteria for disparity. One 
unacknowledged factor that may promote the difference in men and women is considering other 
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tobacco products consumption. All studies mentioned smoking as the one and only source of 
consuming tobacco, while other alternative of tobacco products may affect and altered smoking 
behavior. Other potentially important factors may include pregnancy and lactation, which often 
affects life style regarding smoking and physical activity for women. The quality of physical 
activity (e.g. change in heart beats) was not mentioned in the included studies. Six studies for 
assessing the effect of physical activity and seven studies for assessing the effect of smoking 
may be insufficient to draw a conclusion. The endpoint in included studies were HF 
presentation. Any attempt to describe the epidemiology must take into account the difficulty in 
the diagnosis of HF. Another problem for prevalence estimation is how the researchers take 
into account the asymptomatic HF patients. Subclinical HF might be present and undiagnosed 
due to compensatory mechanisms or sedentary life style, which does not provoke need for 
increase in cardiac output. The discovery of first ANF and then BNP (NT-proBNP) in the 
1980s, and the development of their use as biomarkers of HF was a great advancement. With 
no elevation of BNP, HF is unlikely, but elevated BNP does not alone confirm the diagnosis. 
Additional, more specific biomarkers might be available in the future making population 
studies of HF easier.   
The process of selection of studies, data extraction, and assessing risk of bias are recommended 
to be conducted by at least two authors (111), but in this thesis it has done by the candidate 
alone. The search strategy was comprehensive, but still there is a risk of unidentified studies 
and risk of bias as the review was done by one person.  
4.5 Agreements and disagreements with other studies or 
reviews 
In different study reports, the overall prevalence of HF varies from 3/1000 in RCGP (1958) UK 
national data, Framingham (1971) Framingham, USA, and Landahl et al (1984) Sweden (males 
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only), to 21/1000 in Garrison et al (1966) Georgia, USA. Considering aged population, the 
range of HF prevalence varies from 28/1000 for older than 65 years in Parameshwar et al (1992) 
London, UK, to 130/1000 for older than 67 years in Eriksson et al (1989) Gothenburg, Sweden 
(18). Several risk factors have been previously identified for incident of HF. However, a 
systemic review of large population studies may provide the opportunity to examine the 
consistency of the results of various studies to draw a conclusion. We found higher HF incident 
rates for men than women that is consistent with previous sex-stratified studies (103). An article 
published in a public health journal in 1996 discussed the higher risk of HF among men 
compared to women (129), and further evidence clearly shows higher overall HF risk among 
men (27, 130, 131).  
Current preventive guidelines assume CVDs as a single family of related diseases, while studies 
have shown important differences within different types of CVDs (109). Initial occurrence of 
one CVD strongly influence the development of another (e.g. MI predisposes to HF).  
Current evidence supports that smoking consistently increases risk of HF (132-134). Hence, 
abstinence from smoking plays an important role in reducing the public health burden of HF 
worldwide. Our review confirms and extend results of previous studies that firstly, abstinence 
from smoking has a stronger effect on HF risk reduction than physical activity, and secondly, 
by abstinence from smoking, women may benefit more than men in reducing the risk of HF. 
Few previous cohort studies have examined the sex-stratified association between smoking 
cigarettes with HF. According to a Swedish cohort studies of men in Gothenburg, smoking at 
age of 50 years increased risk of CHF by 60%, RR= 1.6, 95% CI (1.2, 3.2), after adjusting for 
other important risk factors such as HTN (135). The etiology of HF has been changing through 
the time due to progress in HTN management and interventions and medications development 
for CAD therapies (136). CHD is a major cause of HF, therefore, these findings imply that 
smoking cigarettes might directly increase the risk of HF, in addition to its effects on increasing 
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risk HTN and CHD. Thus, smoking cessation should be an important component of HF 
preventive strategies in general population, particularly for women. Smoking, AF, and DM 
showed stronger associations with HF development in women compared to men (103). The 
study of Dunlay et al. (4) showed smoking increased risk of HF in women more than in men 
which is consistent with observation in this review.  
Many observations and studies suggest that physical activity reduce risk of HF (34, 126, 137, 
138). But recommendations on types and amount has been discussed. All adults regardless of 
their age are encouraged to engage in high physical activity (34). Physical activity can reduce 
the risk of HF through different paradigm e.g. by regulating weight, BMI and body composition 
(Figure 13). It has been suggest that a lean but sedentary life style has higher risk of HF than 
an overweight but active life style (117). This study did not discuss the body composition 
regarding balance between fat and muscles. A masculine body with a body composition of 
muscles and higher BMI may not have the same risk factor as the body with the composition 
of more fat but lower BMI. This may suggest that physical activity benefit HF via an 
independent physiological pathway (Figure 13). This perspective about HF pathophysiology 
may extends our understanding of risk factors for HF in other ways. 
4.6 Study strength and limitation  
Strengths of this review are the linkage of multiple large population studies with a large number 
of incident HF cases diagnosed. This allowed for review of studies with large samples. 
Moreover, information for outcome was objective with a high accuracy as data on diagnoses of 
HF were acquired by health registries rather than self-reports. Another strength is that we were 
aware of the variables in each study adjusted for potential confounders. HF is a long-term 
outcome, and follow-up duration was considered long enough in all of the included studies. 
However, several limitations of this review should be considered. We used data from different 
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data sources, which have had their own measurement errors. Due to the nature of the included 
studies in the review, the accuracy and the amount of detailed information recorded are limited. 
Residual confounding may impact the observed associations. There are missing data and 
inconsistency in the reported results which can exemplified by limitation of each study by lack 
of information on clinical important biomarkers and measurements for HF (e.g. 
echocardiography, cholesterol level, blood pressure, serum creatinine). These aforementioned 
factors could help the researchers to evaluate the potential intermediates of the associations of 
exposures with HF risk. Not all studies provide a clear description of the definition of smoking 
and physical activity, which likely caused a greater degree of heterogeneity. This types of 
heterogeneity include variability in the participants, which may lead to heterogeneity in the 
exposure effect. Differences between included studies in terms of exposure measurement 
methods may lead to differences in the observed outcome, and heterogeneity in outcomes 
measures does not necessarily suggest that the true exposure effect varies. Information on 
smoking and physical activity was obtained only at the baseline from a self-administered 
questionnaire. It might be possible that some participants have changed their smoking habits or 
physical activity habits during follow-up. Considering that information of exposures collected 
before the outcomes presentation, misclassification of exposures might happen and caused an 
underestimation of the magnitude of the association. We mostly reviewed adult populations, 
hence, we cannot generalize our data to younger population. Finally, the included studies are 
limited by lack of information about the dosage of smoking, so, we were unable to examine the 
results in a dose-response fashion.   
 
 
Page 50 of 97 
5 Conclusions 
5.1 Implication for practice and research 
Cellular molecular mechanisms differ between women and men in terms of structures of the 
organ and hormonal systems and receptors of chemical signals. Behaviors and habits lead to 
gender differences in risk factors for HF such as diet and physical activity, and medication, 
treatment and follow-up procedures will be different in different social situations. Therefore, 
knowledge of gender differences may affect the preventive, diagnostic and therapeutic 
guidelines of HF and CVD.  
The heterogeneous associations between smoking and physical activity and the risk of HF 
suggest variations in the underlying mechanisms in men and women, which highlights the 
implications for research, clinical screening and risk prediction. Animal models and clinical 
studies offer convincing evidence for dimorphism of sex in heart structure, mechanism and 
diseases. We need general academic agreement about terminology of HF in clinical studies. 
Interaction of physical activity, smoking behavior and gender affect the risk of HF and requires 
further investigations. Much of the evidence related to HF is based on observational studies. 
Randomized controlled trials with a focus on prevention, instead of treatment and management, 
are needed with consideration of the ethical aspects in designing clinical trials when it is well-
documented that smoking and physical inactivity increase risk of HF development. 
5.2 Implication for public health 
There is evidence for the importance of focus on prevention of HF. For example, early and 
intensive treatment for systematic hypertension can reduce up to 64% of the incidence of HF 
(25, 139). Similarly, interventions that can address major risk factors directly or indirectly 
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should be taken into account. In order to reduce the burden of HF, sex-related (biologic) and 
gender-related (sociocultural) research are suggested (22, 59, 140). In this study, we aim to 
provide a comprehensive summary of evidence to assess the generalizability of our findings 
across all types of participants. Our data would be useful as a support in policy making in order 
to plan interventions to increase the population level of cardiovascular health. Gender and age 
targeted interventions should be considered for smoking cessation and improving physical 
activity to decrease the rate of HF. 
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Appendices 
Appendix 1 
Search strategies   
MEDLINE:   
Search through PubMed platform  
(Filters: Humans; MEDLINE):  
#1 "Heart Failure"[Mesh] OR heart failure/tw OR "Cardiovascular Diseases"[Mesh] or 
"Cardiovascular Diseases"tw  
#2 "Cigarette Smoking"[Mesh] OR "Tobacco Smoking"[Mesh] OR "Smoking"[Mesh] OR 
smoking OR "Smoking Tobacco"[Mesh] OR "Exercise"[Mesh] OR (Physical activity) OR 
Physical inactivity OR sedentary lifestyle 
#3 "Sex Characteristics"[Mesh] OR (gender difference)   
#4 (#1 AND #2 AND #3)  
  
EMBASE:  
Search through Ovid platform  
(limit 5 to “human” and exclude “MEDLINE journals” and “EMBASE status”)  
#1 heart failure*/tw OR heart failure/exp OR heart failure.mp OR Cardiovascular disease/tw 
OR Cardiovascular/exp  
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# 2 smoking*/tw OR smoking/exp OR cigarette smoking/tw OR smoking cessation/tw OR 
smoking habit/tw OR tobacco smoke/tw OR tobacco/tw OR tobacco/exp OR physical 
activity*/tw OR physical activity/exp OR Physical fitness.mp. OR fitness/tw OR   
Physical fitness/exp OR sedentary lifestyle.mp. OR sedentary lifestyle/tw OR physical 
activity/tw OR exercise/tw OR sedentary lifestyle/exp  
# 3 gender differences*/tw OR gender difference.mp. OR sex difference/tw OR gender 
differences.mp. OR sex difference/tw OR gender difference/exp sex difference.mp. OR sex 
difference/tw OR sex differences.mp. OR sex difference/tw OR sex difference/exp   
#4 (#1 AND #2 AND #3) 
 
3. CINHAL:  
Chosen databases: CINAHL Plus with Full Text  
#1 heart failure   
#2 smoking OR smoking cigarette OR smoking tobacco OR smoking cessation OR lifestyle 
factor OR Physical activity OR physical fitness OR sedentary lifestyle OR lifestyle risk factor 
OR Physical inactivity   
#3 Gender differences OR sex differences OR gender OR sex   
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Appendix 2 
Studies assessing the effect of smoking and heart failure  
1. Alicia Uijl, UK, 2019, UK-based CALIBER, 
Risk Factors for incident heart failure in age- and sex-specific strata: a population-based cohort 
using linked electronic health records 
2. Jiang He, US, 2001, NHANES 1 Epidemiologic Follow-up Study 
Risk Factors for Congestive Heart Failure in US Men and Women 
3. Susanna C. Larsson, 2016 
Healthy Lifestyle and Risk of Heart Failure  
Results from 2 Prospective Cohort Studies  
4. Yujie Wang, 2011, Finland, FINRISK 
Lifestyle Factors in Relation to Heart Failure Among Finnish Men and Women 
5. Mark Alexander, 1995, USA, A large Health Maintenance Organization Study (HMO) 
Hospitalization for Congestive Heart Failure 
6. Mar Pujades-Rodriguez, 2015, Oxford, UK, the CALIBER program, 
Heterogeneous association between smoking and a wide range of initial presentations of 
cardiovascular disease in 1 937 360 peoples in England: Lifetime risks and implications for risk 
prediction 
7. Andreas Kalogeropoulos, 2009, USA, 
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(103) 
Title, Author, Study Name, Year Risk Factors for incident heart failure in age- and sex-specific strata: a population-based cohort 
using linked electronic health records, Alicia Uijl, UK, 2019, UK-based CALIBER 
Methods Cohort Study 
Participants 871 687 free of HF at baseline (large electronic health records) Men= 381 314, Women= 442 
369 
Ages of Participants ≥ 55 y/o (55-64, 65-74, ˃75) 
HF cases 47 987 Men= 23 314, Women= 24 
673 
Mean year of follow-up duration 5.8 y/o (2.7-9.9 years), median time to event: 3.7 years From 2000 to 2010 
Exposure Smoking (Never, current, Ex: (quit: <2y, 2-5 y, 5-10y, ˃10y) 
Outcomes The Primary Endpoint: First records of HF from primary or secondary care 
Results 
Multivariate Hazard Ratio 
All statistically significant (p<0.001) 
Men: Current: (55-64y/o): 1.27 (1.15-1.43)             Ex-Smoker: 1.08 (0.96-1.21)  
                              (65-74 y/o): 1.15 (1.07-1.24)                                 1.03 (0.97-1.10) 
                              (75 ≤): 1.06 (0.96-1.17)                                         1.00 (0.94-1.06) 
Women: Current: (55-64y/o): 1.35 (1.20-1.52)              Ex-smoker: 1.15 (1.44-1.70) 
                              (65-74 y/o): 1.21 (1.11-1.33)                                 1.30 (1.23-1.38) 
                              (75 ≤): 1.09 (0.99-1.20)                                         1.16 (1.11-1.20) 
Bias Authors' judgement Support for judgement 
 Selection bias Low risk 
“… A cohort of 871687 individuals was constructed from the CALIBER 
resource…which links four sources of HER in England... Individuals were included 
if they were 55years or older between 1 January 2000 and 25 March 2010, if they 
had been registered with a general practitioner for at least 1year, in a practice 
that had at least 1year of up-to-standard data recording in CPRD… The last date 
of the previously mentioned occasions was considered cohort entry date (index 
date)…” (103) 
Performance bias High risk 
“…smoking status as never, ex- or current smokers… Baseline risk factors were 
identified as the closest measurement to index date up to 3years before and 1year 
after. index date…” (103) 
Risk of recall bias for self-reported data about smoking 
Detection bias Low risk 
“…The primary endpoint was incident HF and was based on the first record of HF 
from CPRD or HES…were defined by a diagnosis of HF or diagnosis of chronic left 
ventricular dysfunction on echocardiogram with READ codes, and in HES by a 
diagnosis of HF with ICD-10. Secondary endpoint was the first record of HF, 
excluding patients with a previous myocardial infarction (MI) event at baseline…” 
(103) 
According to CALIBER data base document, HF diagnosed with: “…clinical details in the PC 
record relevant to diagnosis and management, including LV dysfunction confirmed by 
cardiac imaging, an elevated BNP concentration, referral to HF care, referral to a 
cardiologist, the use of loop diuretics, and symptoms and signs suggestive of HF…”(128) 
Attrition bias Low risk 
“…Missing data in all baseline risk factors were imputed, except comorbidities and 
prescriptions, using multiple imputation, from the mice algorithm in the statistical 
software package R…” (103) 
Reporting bias Unclear risk  
Other bias High risk All measurements are prone to measurement error and/or misclassification. To define HF, 
they used data from two different EHR sources, each having their own measurement error. 
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(37) 
Title, Author, year, study 
name 
Risk Factors for Congestive Heart Failure in US Men and Women, Jiang He, US, 2001, 
NHANES 1 Epidemiologic Follow-up Study 
Methods Prospective Cohort Study 
Participants 13 643 Men= 5 545, Women= 8 098 
Ages of Participants 24 – 74 y/o (1 to 74 y/o) 
Heart Failure cases 1 382  Men= 741, Women= 641 
Mean year of follow-up 
duration 
19 years  
(1971, 1975, 1992) 
Exposure Smoking 
Outcomes Congestive Heart Failure 




Support for judgement 
Selection bias High risk “…a multistage, stratified, probably sampling design was used to select a 
representative sample of the US civilian …certain population subgroups, 
including those with a low income, women at childbearing age…and elderly 
…were oversampled…”   (37) 
Performance 
bias 
Low risk “…smoking status was obtained in a random subsample of 6913 participants 
who underwent a more detailed evaluation of the time of their 
examination…smoking status at baseline was derived from responses to 
questions regarding lifetime smoking history administered at follow-up 
interviews …” (37) 
 
The reliability of surrogate information on smoking were checked and it was 85% to 
90% (121) 
Detection bias Low risk “…obtaining hospital … records …pathology reports, electrocardiograms… 
death certificates…” (37) 
Validity of the outcome checked elsewhere (122)   
Attrition bias Low risk They started by 14407 and after exclusion they ended up by 13634 participants. They 
exclude CVD patients, people who lost to follow up. 
Reporting bias Unclear risk  
Other bias High risk Detected diabetes CHF with self reported information, follow up of participants was 
passive rather than active fashion. Electrocardiography and echocardiography were 
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Title, author, year, study name Healthy Lifestyle and Risk of Heart Failure, Susanna C. Larsson, 2016, (Result from 2 
Prospective Cohort Studies), Sweden 
Methods In Two population-based prospective cohort study Residing in Orebro or Vastmanland County 
Participants 64 679 
 
Men= 33 966 (Cohort of Swedish Men): COSM, 
Women= 30 713 (Swedish Mammography Cohort): 
SMC 
Ages of participants 45 – 83 years free of HF and IHD at Baseline 
Heart failure cases 2 584 Men= 1 488, Women= 1 096  
Mean year of follow-up duration 13 years From  1 Jan 1998 to: 31 Dec 2010 
Exposure Smoking: (never or ever) vs (current smoker), a current nonsmoker versus current smoker 
Outcomes Heart failure diagnosis 
Results 
Cox proportional regression  
Men: Physically inactive = 1.00, Physically active = 0.83 (0.74-0.94) 
Women: Physically inactive = 1.00, Physically active = 0.71 (0.63-0.81) 
Bias Authors' judgement Support for judgement 
Selection bias Low risk  “…The COSM was initiated in the late autumn of 1997 when 48 850 
men who were 45 to 79 years of age … The SMC began in 1987 to 
1990 when all women who were born between 1914 and 1948 … 
received a questionnaire about diet and reproductive factors. SMC 
participants received an expanded questionnaire (similar to the 
questionnaire used in the COSM) in the autumn of 1997; 39 227 
women (49−83 years of age in 1997) completed the questionnaire...” 
(114) 
Performance bias High risk “…information on smoking, physical activity, and other major risk 
factors for cardiovascular disease was obtained first in 1997, the 
1997 questionnaire…” (114) 
Risk of recall bias 
Detection bias Low risk Incident of HF were ascertained by linkage with the Swedish National Patient 
Register and the Swedish Cause of Death Register.   ICD10 & ICD11: I50, the 
validation of Swedish Patient Register found 95% of primary HF diagnosis 
were definite HF.    
Attrition bias Low risk “…Men and women were excluded if they had an incorrect or a 
missing personal identification number (n=297 men and n=243 
women), had a previous diagnosis of HF or ischemic heart disease 
(n=4823 men and n=1891 women) or cancer other than 
nonmelanoma skin cancer (n=2592 men and n=1811 women), or 
died between the administration of 1997 questionnaire and start of 
follow-up (January 1, 1998; n=55 men and n=26 women). Those with 
extreme energy intakes (ie, 3 SDs from the loge-transformed mean 
energy intake in men and women separately; n=468 men and n=432 
women) or with missing data on any of the lifestyle factors (including 
missing information on any component of the Mediterranean diet; 
n=6649 men and n=4111 women) were also excluded...” (114) 
48 850 men and 39 227 women, ended up in 33 966 men and 30 713 women 
for analysis. 
Reporting bias Unclear risk  
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Title, author, year, study name Lifestyle Factors in Relation to Heart Failure Among Finnish Men and Women, Yujie 
Wang, 2011, Finland, FINRISK 
Methods Prospective cohort  
Participants 38 072 Men= 18 346, Women= 19 726 
Ages of participants 25 – 64 y/o, 65 – 74 y/o 
Heart failure cases 1 083 Men= 638, Women= 445 
Mean year of follow-up 
duration 
14.1 years (5.9-20.9), 1982, 1987, 1992, 1997, 2007 
Exposure Participants classified as never, ex-smoker and current smoker. 
“…Participants were classified as never, ex-smokers and current smokers, based 
on their responses to the questionnaire.”(2) 
Outcomes Heart failure 
Results Men: Light = 1.00, Moderate= 0.79 (0.64-0.97), High = 0.67 (0.53-0.86) 
Women: Light = 1.00, Moderate= 0.87 (0.70-1.08), High = 0.64 (0.48-0.86) 
Bias Authors' 
judgement 
Support for judgement 
Selection bias Low risk “…Five independent cross-sectional, population-based health examination 
surveys (FINRISK) … in 6 geographic areas of Finland in 1982, 1987, 1992, 1997, 
and 2002…. stratified by area, sex, and 10-year age group according to (WHO) 
…protocol…” (2) 
Performance bias High risk A self-administered questionnaire was mailed to the participants …, 
smoking,… Data on the history of myocardial infarction or diabetes 
mellitus at baseline were obtained from the questionnaire and 
collected by hospital discharge diagnosis or drug register… valvular 
heart disease at baseline were collected by hospital discharge 
register”(2) 
Risk of recall bias 
Detection bias Low risk “…ascertain HF cases … has been used in Scandinavian countries,… positive 
predictive value of HF diagnosis to be 82% (false-positive rate, 18%)… found 
the specificity of the HF diagnoses to be acceptable for the epidemiological 
study…”(2) 
Attrition bias Low risk “…The total sample size…was 38 737. The final sample comprised 18 346 men 
and 19 729 women after excluding the participants with a history of HF 
(n=457) at baseline and the participants with incomplete data on any variables 
required for this analysis (n=205)…” (2) 
Reporting bias Unclear risk  
Other bias High risk “Information were collected on self-reported for physical activity and smoking, 
once at baseline. No data on possible changes on lifestyle factors during 
follow-up… Cannot completely either exclude the effects of residual 
confounding due to measurement error in the assessment of confounding 
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Title, author, year, study Name Hospitalization for Congestive Heart Failure, Mark Alexander, 1995, USA, A large Health 
Maintenance Organization Study (HMO) 
Methods Retrospective Cohort Study 
Participants 64 877 (27% African American, 73% 
White) 
Men= 27 708, Women= 30 134 
Ages of participants ≥40 years free of CHF at baseline 
Heart failure cases 1 330 Men= 618, Women= 712 
Mean year of follow-up duration 9.5 years (ranged from 1 month to 14.9 
years) 
1960s- 1991, they received MHC between 
1978 and 1984  
Exposure Smoked ˃ 1 year, healthcare reports were used 
Outcomes Heart Failure (First Hospitalization with a principle diagnosis of CHF) 
Results Men; age< 60, Smoke ˃ 1 year, 2.18 (1.46-3.25), Women; age< 60, Smoke ˃ 1 year, 1.64 
(1.12-2.39) 
Bias Authors' judgement Support for judgement 
Selection bias Low risk Participants of Northern California Kaiser Permanent Medical Care Program Who 
took at the Kaiser Permanent Medical Care Program. Who took at least one 
multiphasic checkup (MHC) at the age of 40 and were free of HF at the time. They 
collected medical and social history questionnaire, a series of clinical laboratory tests, 
a chest x-rays, electrocardiogram, and an examination by a physician. 
Performance 
bias 
High risk Self-reported data base by asking from patients. 
Risk of recall bias 
Detection bias Low risk Used hospital databases 
Attrition bias High risk They did not mention to the number of participants that excluded during the follow 
up time 
Reporting bias Unclear risk   
























Title, author, year, study 
name 
Heterogeneous association between smoking and a wide range of initial presentations of 
cardiovascular disease in 1 937 360 peoples in England: Lifetime risks and implications 
for risk prediction, Mar Pujades-Rodriguez, 2015, Oxford, UK, The CALIBER 
programme 
Methods Population-based Cohort Study of electronic health records 
Participants 1 937 360, Smoking status data: 1 
413 749 
Men= 1 605 729, Women= 1 745 380 
Ages of participants ≥ 30 y/o 
Heart failure cases 14 359 Men= 6 206, Women= 8 153 
Mean year of follow-up 
duration 
5.5 year (6 years), 11.6 million person-
year 
From 1st Jan 1997 to 25th March 2010 
Exposure Examined association of smoking and smoking cessation based on sex 
classified in: 
#Never smoker #ex-smoker #current smoker   
Ex-smokers were grouped into categories of time since quitting (<2, 2-5, 5-10, ˃10 
years and missing) 
Outcomes 12 CVD presentations including Heart failure 
Results Men: Never = 1.00, Current = 1.57 (1.40-1.77) 
Women: Never = 1.00, Current = 1.77 (1.47- 2.13) 
Bias Authors' judgement Support for judgement 
Selection 
bias 
Low risk “…cohort of 1937360 patients drawn from individuals registered in the general 
practices in England contributing with data to the CALIBER programme, 
between January 1997 and March 2010, was analysed. Patient data were linked 
across four data source…”  
Performance 
bias 
High risk Patients self-reported smoking status was prospectively collected. The most 
recent smoking record before the study entry was used.  
Risk of recall bias 
Detection 
bias 
Low risk Check through the available data bases of CALIBER study  
Attrition 
bias 
High risk Start with 5372 790 participants and ended up in 1 937 360 
Reporting 
bias 
Low risk Through the access to their supplementary file  
Other bias High risk “…unavailable and residual confounding cannot be completely 
excluded…Smoking status might also have changed over time, and 
this could have resulted in underestimation of associations… to define 
CVDs we used data from four different EHR sources, each of which has 
its own error…unable to resolve disease subtypes including systolic or 
diastolic heart failure, which might mask an even greater degree of 
heterogeneity… cannot exclude that some associations might have 
resulted from multiple testing” (109) 
 




Title, Author, Study 
Name, Year 
Epidemiology of Incident Heart Failure in a contemporary Elderly Cohort, Andreas 
Kalogeropoulos, 2009, USA, Health ABC study 
Methods Population-based study of 3075 community-dwelling Cohort 
Participants 2 934 Men= 1 405, Women= 1 529 
Ages of participants 70 – 79 y/o (mean age = 73.6 ± 2.9) 
Heart failure cases 258 (8.8%), 13.6 per 1000 p.y (12.1-
15.4) 
Men= 140, Women= 118 
Mean year of follow-up 
duration 
7.1 years Follow-up (25th-75th: 6.6- 7.5 
years) 
From April 1997 to June 1998 
Exposure Smoking (Current, past (if ≥100 lifetime cigarettes) or never.  
Outcomes Heart Failure 
Results White: Men: Current = 1.32 (0.42-3.21) 
Women: Current = 1.88 (1.01-3.35) 
 Black: Men: Current = 2.72 (1.17-5.64) 
Women: Current = 1.75 (0.85-3.32) 
Bias Authors' judgement Support for judgement 
Selection 
bias 
High risk “…The Health ABC Study is a population-based study of 3075 
community-dwelling men and women aged 70 to of 3075 community-
dwelling Cohort…Cardiovascular disease status at baseline, including 
prevalent HF, was based on self-reported history,”(116) 
Risk of recall bias 
Performance 
bias 
High risk Questionnaire, self reported  
Detection 
bias 
High risk “…Local adjudicators classified events as HF based on symptoms, signs, 
chest radiograph results, and echocardiographic findings based on 
criteria similar to those used in the Cardiovascular Health Study. The HF 
criteria required at least a HF diagnosis from a physician and treatment 
for HF (i.e., a current prescription for a diuretic agent and either digitalis 
or a vasodilator); these criteria have been used in previous 
investigations. Because HF was not allowed as a cause of death, there 
were no deaths from incident HF…”(116) 
Attrition 
bias 
Low risk “…Of 3075 subjects enrolled in the Health ABC Study, 95 had definite or 
possible HF at baseline, and 46 were excluded because of missing data 




Unclear risk  
Other bias High risk “…was based on HF hospitalization; therefore, we likely underestimated 
the true incidence. Echocardiography was not performed…The Health 
ABC Study did not collect detailed data on valvular heart disease; 
however, it is unlikely that a large proportion of participants had 
significant subclinical valvular heart disease that would affect the 
results overall…because ventricular function during hospitalization for 
HF was not prospectively assessed, we could not reliably assess the 
differential effect of risk factors on development of HF with preserved 
vs reduced LVEF….The available data on LVEF are based on medical 
record reviews and do not refer to a single modality. Therefore, we 
cannot be confident that the distribution of LVEF is representative of 
older persons hospitalized with new-onset HF…These differences may 
represent sex, race, severity of illness, or therapy related 
differences…”(116) 
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Appendix 3 
Studies for the effect of physical activity effect and heart failure 
1. Alicia Uijl, 2019, UK, UK-based CALIBER 
Risk Factors for incident heart failure in age- and sex-specific strata: a population-based cohort 
using linked electronic health records 
2. Jiang He, 2001, USA, NHANES 1 Epidemiologic Follow-up Study 
Risk Factors for Congestive Heart Failure in US Men and Women 
3. Susanna C. Larsson, 2016, Sweden 
Healthy Lifestyle and Risk of Heart Failure  
Results from 2 Prospective Cohort Studies 
4. Yujie Wang, 2011, Finland, FINRISK 
Lifestyle Factors in Relation to Heart Failure Among Finnish Men and Women 
5. Gang Hu, 2009, Finland, 
Joint effect of Physical Activity, Body Mass Index, Waist Circumference, and Waist-to-Hip 
Ratio on the Risk of Heart Failure 
6. Yujie Wang, 2010, Finland, 
Occupational, Commuting, and Leisure-Time Physical Activity in Relation to Heart Failure 
Among Finnish Men and Women 
Gang Hu et al, 2009 and Yujie Wang et al, 2010 and Yujie Wang et al, 2011 used the same 
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Title, author, study name, year Risk Factors for incident heart failure in age- and sex-specific strata: a population-based cohort 
using linked electronic health records, Alicia Uijl, UK, 2019, UK-based CALIBER 
Methods Cohort study 
Participants 871 687 free of HF at baseline (a large electronic health 
records) 
Men= 381 314, Women= 442 
369 
Ages of participants ≥ 55 y/o (55-64, 65-74, ˃75) 
HF cases 47 987 Men= 23 314, Women= 24 673 
Mean year of follow-up duration 5.8 y/o (2.7-9.9 years), median time to event: 3.7 years From 2000 to 2010 
Exposure Sedentary lifestyle  
Outcomes The Primary Endpoint: First records of HF from primary or secondary care 
Results (Hazard Ratios)  
all HR are statistically significant: 
p<0.001 
Men: (55-64y/o): 1.06 (0.99-1.13), (65-74 y/o): 1.11 
(1.04-1.17), (75 ≤): 1.09 (1.02-1.16) 
Women: (55-64y/o): 1.09 (1.00-1.19), (65-74 y/o): 
1.09 (1.01-1.17), (75 ≤): 1.08 (1.02-1.15) 
Multiple regression analysis: Men: (55-64y/o): 9.07 (4.97-
12.84), (65-74 y/o): 5.03 (2.35-7.97), (75 ≤): 5.31 (1.83-9.06) 
Women: (55-64y/o): 5.96 (1.56-10.41), (65-74 y/o): 5.69 (1.19-
9.79), (75 ≤): 6.36 (1.49-10.78) 
Bias Authors' judgement Support for judgement 






“… A cohort of 871687 individuals was constructed from the CALIBER resource…which 
links four sources of HER in England... Individuals were included if they were 55years 
or older between 1 January 2000 and 25 March 2010, if they had been registered with 
a general practitioner for at least 1year, in a practice that had at least 1year of up-to-
standard data recording in CPRD… The last date of the previously mentioned occasions 






“…patient’s level of physical activity as recorded in primary care was classified as 
sedentary life style or active life style. Definitions of all risk factors can be found at … 
Baseline risk factors were identified as the closest measurement to index date up to 
3years before and 1year after. index date…” (103) 




“…The primary endpoint was incident HF and was based on the first record of HF from 
CPRD or HES…were defined by a diagnosis of HF or diagnosis of chronic left ventricular 
dysfunction on echocardiogram with READ codes, and in HES by a diagnosis of HF with 
ICD-10. Secondary endpoint was the first record of HF, excluding patients with a 
previous myocardial infarction (MI) event at baseline…” (103) 
According to CALIBER data base document, HF diagnosed with: “…clinical details in the PC record 
relevant to diagnosis and management, including LV dysfunction confirmed by cardiac imaging, 
an elevated BNP concentration, referral to HF care, referral to a cardiologist, the use of loop 
diuretics, and symptoms and signs suggestive of HF…”(128) 
Attrition bias Low risk 
“…Missing data in all baseline risk factors were imputed, except comorbidities and 
prescriptions, using multiple imputation, from the mice algorithm in the statistical 
software package R…” (103)  
Reporting bias Unclear risk  
Other bias High risk All measurements are prone to measurement error and/or misclassification. To define HF, they 
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Title, author, year, study name Risk factors for congestive heart failure in US men and women, Jiang He, US, 2001, 
NHANES 1 Epidemiologic Follow-up Study 
Methods Prospective cohort study 
Participants 13 643 Men= 5 545, Women= 8 098 
Ages of participants 1 – 74 y/o  
Heart failure cases 1 382  Men= 741, Women= 641 
Mean year of follow-up duration 19 years (1971, 1975, 1992) 
Exposure Recreational physical activity, Having regular physical activity 
Outcomes Congestive heart failure 




Support for judgement 
Selection bias High risk “…a multistage, stratified, probably sampling design was used to select a 
representative sample of the US civilian …certain population subgroups, 
including those with a low income, women at childbearing age…and elderly 
…were oversampled…”   (37) 
Performance 
bias 
High risk “…physical activity…obtained based on responses to interview-administered 
questionnaire.”  (37) 
Risk of recall bias  
Detection bias Low risk “…obtaining hospital … records …pathology reports, electrocardiograms… 
death certificates…” (37) 
Validity of the outcome checked elsewhere (122)   
Attrition bias Low risk They started by 14407 and after exclusion they ended up by 13634 participants. They 
exclude CVD patients, people who lost to follow up. 
Reporting bias Unclear risk  
Other bias High risk Detected diabetes CHF with self reported information, follow up of participants was 
passive rather than active fashion. Electrocardiography and echocardiography were 
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Title, author, study name, year Healthy lifestyle and risk of heart failure (Result from 2 prospective cohort studies), Susanna C. 
Larsson, 2016, Sweden 
Methods In two population-based prospective cohort study Residing in Orebro or Vastmanland County 
Participants 64 679  Men= 33 966 (Cohort of Swedish men): COSM 
Women= 30 713 (Swedish mammography cohort): SMC 
Ages of Participants 45 – 83 years free of HF and IHD at Baseline 
Heart Failure cases 2 584 Men= 1 488, Women= 1 096  
Mean year of follow-up duration 13 years From  1 Jan 1998 to: 31 Dec 2010 
Exposure physically active (≥150 min/wk of physical activity) versus inactive (<150 min/wk) 
“Physical activity was assessed with a prior validated questionnaire on time spent 
on various activities during the previous year. In this study, we added up time per 
week spent engaged in walking/bicycling and exercise.” (114) 
Outcomes Heart failure 
Results 
Cox proportional hazard regression 
Men: Physically inactive = 1.00, Physically active = 0.83 (0.74-0.94) 
Women: Physically inactive = 1.00, Physically active = 0.71 (0.63-0.81) 
Bias Authors' judgement Support for judgement 
Selection bias Low risk   “…The COSM was initiated in the late autumn of 1997 when 48 850 men 
who were 45 to 79 years of age … The SMC began in 1987 to 1990 when 
all women who were born between 1914 and 1948 … received a 
questionnaire about diet and reproductive factors. SMC participants 
received an expanded questionnaire (similar to the questionnaire used in 
the COSM) in the autumn of 1997; 39 227 women (49−83 years of age in 
1997) completed the questionnaire...” (114) 
Performance bias High risk “…information on smoking, physical activity, and other major risk factors 
for cardiovascular disease was obtained first in 1997, the 1997 
questionnaire…” (114) 
Risk of recall bias 
Detection bias Low risk Incident of HF were ascertained by linkage with the Swedish National Patient 
Register and the Swedish Cause of Death Register.   ICD10 & ICD11: I50, the 
validation of Swedish Patient Register found 95% of primary HF diagnosis were 
definite HF.    
Attrition bias Low risk “…Men and women were excluded if they had an incorrect or a missing 
personal identification number (n=297 men and n=243 women), had a 
previous diagnosis of HF or ischemic heart disease (n=4823 men and 
n=1891 women) or cancer other than nonmelanoma skin cancer (n=2592 
men and n=1811 women), or died between the administration of 1997 
questionnaire and start of follow-up (January 1, 1998; n=55 men and n=26 
women). Those with extreme energy intakes (ie, 3 SDs from the loge-
transformed mean energy intake in men and women separately; n=468 
men and n=432 women) or with missing data on any of the lifestyle factors 
(including missing information on any component of the Mediterranean 
diet; n=6649 men and n=4111 women) were also excluded...” (114) 
48 850 men and 39 227 women, ended up in 33 966 men and 30 713 women for 
analysis.  
Reporting bias Unclear risk  
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Title, author, year, study name Lifestyle factors in relation to heart failure among Finnish men and women, Yujie Wang, 2011, 
Finland, FINRISK 
Method Prospective cohort  
Participants 38 072 Men= 18 346, Women= 19 726 
Ages of participants 25 – 64 y/o, 65 – 74 y/o 
Heart failure cases 1 083 Men= 638, Women= 445 
Mean year of follow-up duration 14.1 years, (5.9-20.9), 1982, 1987, 1992, 1997, 2007 
Exposure Dichotomized to low vs moderate or high physical activity 
Physical Activity (Occupational, Commuting, and Leisure-Time Physical Activity) 
-occupational PA was divided into 3 categories: (1). Low: sitting at office (2). Walking, (3). High: 
walking and lifting, heavy manual labor 
-daily commuting PA was divided into 3 categories: (1). Motorized transportation or no physical 
work (2). Walking or bicycling 1 to 29 min/day (3). Walking or bicycling more than 30 min/day 
-leisure time PA was divided into 3 categories: (1). Low: almost sitting, (2). Moderate: some PA 
more than 4 h/w, (3). High: vigorous PA more than 3 h/w. 
“…because we found that moderate and high occupational or leisure time physical activity 
independently and significantly reduces risk of HF the groups were merged into 
3categories: “low” when subjects reported light levels of both occupational and leisure 
time physical activity; “moderate” when subjects reported moderate or high level of either 
occupational or leisure time physical activity; and “high” when subjects reported 
moderate or high level of both occupational and leisure time physical activity.”(2) 
Outcomes Heart failure 
Results 
(Multivariable cox regression)  
Men:     Light = 1.00, Moderate= 0.79 (0.64-0.97), High = 0.67 (0.53-0.86) 
Women: Light = 1.00, Moderate= 0.87 (0.70-1.08), High = 0.64 (0.48-0.86) 
Bias Authors' judgement Support for judgement 
Selection bias Low risk “…Five independent cross-sectional, population-based health examination 
surveys (FINRISK) … in 6 geographic areas of Finland in 1982, 1987, 1992, 
1997, and 2002…. stratified by area, sex, and 10-year age group according 
to (WHO) …protocol…” (2) 
Performance bias High risk A self-administered questionnaire was mailed to the participants …, physical 
activity,… Data on the history of myocardial infarction or diabetes mellitus at 
baseline were obtained from the questionnaire and collected by hospital 
discharge diagnosis or drug register… valvular heart disease at baseline were 
collected by hospital discharge register”(2) 
Risk of recall bias 
Detection bias Low risk “…ascertain HF cases … has been used in Scandinavian countries,… positive 
predictive value of HF diagnosis to be 82% (false-positive rate, 18%)… found 
the specificity of the HF diagnoses to be acceptable for the epidemiological 
study…”(2)  
Attrition bias Low risk “…The total sample size…was 38 737. The final sample comprised 18 346 men 
and 19 729 women after excluding the participants with a history of HF 
(n=457) at baseline and the participants with incomplete data on any 
variables required for this analysis (n=205)…” (2) 
Reporting bias Unclear risk  
Other bias High risk “Information were collected on self-reported for physical activity and 
smoking, once at baseline. No data on possible changes on lifestyle factors 
during follow-up… Cannot completely either exclude the effects of residual 
confounding due to measurement error in the assessment of confounding 
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“…Occupational, commuting, and leisure-time physical activity levels were assessed with a self-administered 
questionnaire. …  
occupational physical activity according to the following 3 categories: low (work that is physically very easy such 
as sitting office work [e.g., secretary]), moderate (work including standing and walking [e.g., store assistant and 
light industrial worker]), and high (work including walking and lifting or heavy manual labor [e.g., industrial or 
farm work]). 
 Daily commuting return journey was divided into 3 categories: motorized transportation or no work (no walking 
or cycling), walking or bicycling 1 to 29 minutes per day, or walking or bicycling ˃30 minutes per day.  
Self-reported leisure-time physical activity was classified into 3 categories: low, defined as almost completely 
inactive such as reading, watching television, or doing some minor physical activity but not at a moderate or high 
level; moderate, defined as doing some physical activity ˃4 h/wk such as walking, cycling, or light gardening, 
excluding travel to work; and high, defined as performing vigorous physical activity ˃3 h/wk such as running, 
jogging, swimming, or heavy gardening or competitive sports several times a week.  
Because we found that moderate and high occupational, commuting, or leisure-time physical activity 
independently and significantly reduces risk of HF, the groups were merged into 3 categories: low, which included 
those subjects who reported light levels of occupational, commuting (<1 minute), and leisure-time physical 
activity; moderate, which included those subjects who reported only 1 of the all 3 types of moderate to high 
physical activity; and high, which included those subjects who reported 2 or 3 types of moderate to high physical 
activity. This method had been used to assess other outcomes such as incidence of diabetes mellitus and mortality 




Title, author, year, study name Joint effect of Physical Activity, Body Mass Index, Waist Circumference, and Waist-to-Hip 
Ratio on the Risk of Heart Failure, Gang Hu, 2009, Finland 
Methods Population-based Cohort 
Participants 59 178 Men= 28 842, Women= 30 336 
Ages of participants 24 – 74 y/o 
Heart failure cases 3 614 Men= 1 921, Women= 1 693 
Mean year of follow-up duration 18.4 years 
Exposure Physical activity  
Outcomes Heart failure 
Results 
low, medium and high physical 
activity. 
Men: Low = 1.00, Moderate = 0.79 (0.68-0.92), High= 0.69 (0.60-0.80), p trend<0.001 
Women: Low = 1.00, Moderate = 0.86 (0.75-0.99), High= 0.68 (0.59-0.78), p trend<0.001 
Bias Authors' judgement Support for judgement 
Selection bias Low risk “…Seven independent cross-sectional population surveys … in 6 geographic areas of Finland in 1972, 
1977, 1982, 1987, 1992, 1997, and 2002…according to the (WHO) … (MONICA) protocol.”(117) 
Performance bias High risk “…A self-administered questionnaire was mailed to the participants to be completed at home and 
returned to the survey site. …physical activity, … On the basis of the responses, the participants were 
classified as…”(117) 
Risk of recall bias 
Detection bias Low risk A study from Sweden found the positive predictive value of HF diagnosis to be 82%. Another study from Finland 
confirm the specificity of the HF diagnosis to be acceptable for the epidemiological study. 
Attrition bias Low risk “…total sample size … was 62 013. The final sample comprised 28 842 men and 30 336 women after 
the exclusion of participants with a history of HF (n=998) at baseline, participants who were 
underweight (BMI <18.5 kg/m2) (n =488), and the participants with incomplete data on any variables 
required for this analysis (n=1349). …The excluded participants with incomplete data did not differ 
significantly from remaining participants in mean age and the sex distribution.” (117) 
Reporting bias Unclear risk  
Other bias High risk Information were collected on self-reported for physical activity and smoking, once at baseline. No data on possible 
changes on lifestyle factors during follow-up. Cannot completely either exclude the effects of residual confounding 
due to measurement error in the assessment of confounding factors, or some unmeasured dietary factors. 
 




“… the participants were classified as never smokers, former smokers, and current smokers. 




Title, author, year, study name Occupational, commuting, and leisure-time physical activity in relation to heart failure among 
Finnish men and women, Yujie Wang, 2010, FINRISK, Finland 
Methods Study cohort 
Participants 58 208 free of HF at baseline Men= 28 334, Women= 29 874 
Ages of participants 25 – 74 y/o 
Heart failure cases 3 508 Men= 1 868, Women= 1 640 
Mean year of follow-up duration 18.4 years From 1972 to 2002 
Exposure Physical activity (Occupational, Commuting, and Leisure-Time Physical Activity) 
-occupational PA was divided into 3 categories: (1). Low: sitting at office (2). Walking, (3). High: walking 
and lifting, heavy manual labor 
-daily commuting PA was divided into 3 categories: (1). Motorized transportation or no physical work (2). 
Walking or bicycling 1 to 29 min/day (3). Walking or bicycling more than 30 min/day 
-leisure time PA was divided into 3 categories: (1). Low: almost sitting, (2). Moderate: some PA more than 4 
h/w, (3). High: vigorous PA more than 3 h/w. 




Men: low: 1.00 
Moderate: 0.90 (0.78-1.03), 
p<0.005 
High: 0.83 (0.73-0.93), p<0.005 
Women: low: 1.00 
Moderate: 0.80 (0.70-0.92), 
p<0.007 
High: 0.92 (0.82-1.05), p<0.007 
Leisure Time:  
Men: low: 1.00 
Moderate: 0.83 (0.76-0.92), 
p<0.001 
High: 0.65 (0.54-0.77), p<0.001 
Women: low: 1.00 
Moderate: 0.84 (0.75-0.94), 
p=0.001 
High: 0.75 (0.60-0.94), p=0.001 
Commuting: 
Men: low: 1.00 
Moderate:1.01 (0.90_1.13), 
p<0.954 
High: 0.99 (0.87-1.12), p<0.954 
Women: low: 1.00 
Moderate:0.87 (0.76-0.99), 
p<0.159 
High: 0.94 (0.82-1.07), p<0.159 
Bias Authors' judgement Support for judgement 
Selection bias Low risk “…Seven independent population surveys … in 6 geographic areas of Finland in 1972, 1977, 
1982, 1987, 1992, 1997, and 2002 …the sample was stratified by area, gender, and 10-year 
age group according to the World Health Organization Monitoring Trends and Determinants 
of Cardiovascular Disease protocol…” (53) 
Performance bias Low risk “Occupational, commuting, and leisure-time physical activity levels were assessed using a self-
administered questionnaire only at baseline” (53) 
“…The questionnaire used for the assessment of physical activity has been used successfully 
elsewhere, and it has shown a high correlation with physical fitness, as measured by maximal 
oxygen uptake…”(53) 
Detection bias Low risk “…An HF diagnosis was made by the treating physicians, based on a clinical assessment, X-ray 
examination, and to various extents, echocardiography. Follow-up of each cohort member 
continued until the date of the diagnosis of HF obtained from the Hospital Discharge Register, 
the National Social Insurance Institution’s register or mortality, death resulting from causes 
other than HF, ... The accuracy of the HF cases … more than 80% based on the European 
Society of Cardiology definition” (53) 
Attrition bias Low risk “…The total sample size of the 7 surveys was 62,013. After excluding 998 subjects with a history of HF at 
baseline and 2,807 subjects with incomplete data on any required variables, the present analyses include 
28,334 men and 29,874 women…” (53) 
Reporting bias Unclear risk  
Other bias High risk Assessment of PA (with self-administered questioners only at baseline). Information 
were collected on self-reported for physical activity and smoking, once at baseline. 
No data on possible changes on lifestyle factors during follow-up. 
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